5300192023-10-012024-03-315300192024-03-315300192023-10-012024-03-31RelatedPartyTransactionDomain15300192023-09-30RelatedPartyTransactionDomain15300192024-03-31RelatedPartyTransactionDomain15300192023-10-012024-03-31RelatedPartyTransactionDomain25300192023-09-30RelatedPartyTransactionDomain25300192024-03-31RelatedPartyTransactionDomain25300192023-10-012024-03-31RelatedPartyTransactionDomain35300192023-09-30RelatedPartyTransactionDomain35300192024-03-31RelatedPartyTransactionDomain35300192023-10-012024-03-31RelatedPartyTransactionDomain45300192023-09-30RelatedPartyTransactionDomain45300192024-03-31RelatedPartyTransactionDomain45300192023-10-012024-03-31RelatedPartyTransactionDomain55300192023-09-30RelatedPartyTransactionDomain55300192024-03-31RelatedPartyTransactionDomain55300192023-10-012024-03-31RelatedPartyTransactionDomain65300192023-09-30RelatedPartyTransactionDomain65300192024-03-31RelatedPartyTransactionDomain65300192023-10-012024-03-31RelatedPartyTransactionDomain75300192023-09-30RelatedPartyTransactionDomain75300192024-03-31RelatedPartyTransactionDomain75300192023-10-012024-03-31RelatedPartyTransactionDomain85300192023-09-30RelatedPartyTransactionDomain85300192024-03-31RelatedPartyTransactionDomain85300192023-10-012024-03-31RelatedPartyTransactionDomain95300192023-09-30RelatedPartyTransactionDomain95300192024-03-31RelatedPartyTransactionDomain95300192023-10-012024-03-31RelatedPartyTransactionDomain105300192023-09-30RelatedPartyTransactionDomain105300192024-03-31RelatedPartyTransactionDomain105300192023-10-012024-03-31RelatedPartyTransactionDomain115300192023-09-30RelatedPartyTransactionDomain115300192024-03-31RelatedPartyTransactionDomain115300192023-10-012024-03-31RelatedPartyTransactionDomain125300192023-09-30RelatedPartyTransactionDomain125300192024-03-31RelatedPartyTransactionDomain125300192023-10-012024-03-31RelatedPartyTransactionDomain135300192023-09-30RelatedPartyTransactionDomain135300192024-03-31RelatedPartyTransactionDomain135300192023-10-012024-03-31RelatedPartyTransactionDomain145300192023-09-30RelatedPartyTransactionDomain145300192024-03-31RelatedPartyTransactionDomain145300192023-10-012024-03-31RelatedPartyTransactionDomain155300192023-09-30RelatedPartyTransactionDomain155300192024-03-31RelatedPartyTransactionDomain155300192023-10-012024-03-31RelatedPartyTransactionDomain165300192023-09-30RelatedPartyTransactionDomain165300192024-03-31RelatedPartyTransactionDomain165300192023-10-012024-03-31RelatedPartyTransactionDomain175300192023-09-30RelatedPartyTransactionDomain175300192024-03-31RelatedPartyTransactionDomain175300192023-10-012024-03-31RelatedPartyTransactionDomain185300192023-09-30RelatedPartyTransactionDomain185300192024-03-31RelatedPartyTransactionDomain185300192023-10-012024-03-31RelatedPartyTransactionDomain195300192023-09-30RelatedPartyTransactionDomain195300192024-03-31RelatedPartyTransactionDomain195300192023-10-012024-03-31RelatedPartyTransactionDomain205300192023-09-30RelatedPartyTransactionDomain205300192024-03-31RelatedPartyTransactionDomain205300192023-10-012024-03-31RelatedPartyTransactionDomain215300192023-09-30RelatedPartyTransactionDomain215300192024-03-31RelatedPartyTransactionDomain215300192023-10-012024-03-31RelatedPartyTransactionDomain225300192023-09-30RelatedPartyTransactionDomain225300192024-03-31RelatedPartyTransactionDomain225300192023-10-012024-03-31RelatedPartyTransactionDomain235300192023-09-30RelatedPartyTransactionDomain235300192024-03-31RelatedPartyTransactionDomain235300192023-10-012024-03-31RelatedPartyTransactionDomain245300192023-09-30RelatedPartyTransactionDomain245300192024-03-31RelatedPartyTransactionDomain245300192023-10-012024-03-31RelatedPartyTransactionDomain255300192023-09-30RelatedPartyTransactionDomain255300192024-03-31RelatedPartyTransactionDomain255300192023-10-012024-03-31RelatedPartyTransactionDomain265300192023-09-30RelatedPartyTransactionDomain265300192024-03-31RelatedPartyTransactionDomain265300192023-10-012024-03-31RelatedPartyTransactionDomain275300192023-09-30RelatedPartyTransactionDomain275300192024-03-31RelatedPartyTransactionDomain275300192023-10-012024-03-31RelatedPartyTransactionDomain285300192023-09-30RelatedPartyTransactionDomain285300192024-03-31RelatedPartyTransactionDomain285300192023-10-012024-03-31RelatedPartyTransactionDomain295300192023-09-30RelatedPartyTransactionDomain295300192024-03-31RelatedPartyTransactionDomain295300192023-10-012024-03-31RelatedPartyTransactionDomain305300192023-09-30RelatedPartyTransactionDomain305300192024-03-31RelatedPartyTransactionDomain305300192023-10-012024-03-31RelatedPartyTransactionDomain315300192023-09-30RelatedPartyTransactionDomain315300192024-03-31RelatedPartyTransactionDomain315300192023-10-012024-03-31RelatedPartyTransactionDomain325300192023-09-30RelatedPartyTransactionDomain325300192024-03-31RelatedPartyTransactionDomain325300192023-10-012024-03-31RelatedPartyTransactionDomain335300192023-09-30RelatedPartyTransactionDomain335300192024-03-31RelatedPartyTransactionDomain335300192023-10-012024-03-31RelatedPartyTransactionDomain345300192023-09-30RelatedPartyTransactionDomain345300192024-03-31RelatedPartyTransactionDomain345300192023-10-012024-03-31RelatedPartyTransactionDomain355300192023-09-30RelatedPartyTransactionDomain355300192024-03-31RelatedPartyTransactionDomain355300192023-10-012024-03-31RelatedPartyTransactionDomain365300192023-09-30RelatedPartyTransactionDomain365300192024-03-31RelatedPartyTransactionDomain365300192023-10-012024-03-31RelatedPartyTransactionDomain375300192023-09-30RelatedPartyTransactionDomain375300192024-03-31RelatedPartyTransactionDomain375300192023-10-012024-03-31RelatedPartyTransactionDomain385300192023-09-30RelatedPartyTransactionDomain385300192024-03-31RelatedPartyTransactionDomain385300192023-10-012024-03-31RelatedPartyTransactionDomain395300192023-09-30RelatedPartyTransactionDomain395300192024-03-31RelatedPartyTransactionDomain395300192023-10-012024-03-31RelatedPartyTransactionDomain405300192023-09-30RelatedPartyTransactionDomain405300192024-03-31RelatedPartyTransactionDomain405300192023-10-012024-03-31RelatedPartyTransactionDomain415300192023-09-30RelatedPartyTransactionDomain415300192024-03-31RelatedPartyTransactionDomain415300192023-10-012024-03-31RelatedPartyTransactionDomain425300192023-09-30RelatedPartyTransactionDomain425300192024-03-31RelatedPartyTransactionDomain425300192023-10-012024-03-31RelatedPartyTransactionDomain435300192023-09-30RelatedPartyTransactionDomain435300192024-03-31RelatedPartyTransactionDomain435300192023-10-012024-03-31RelatedPartyTransactionDomain445300192023-09-30RelatedPartyTransactionDomain445300192024-03-31RelatedPartyTransactionDomain445300192023-10-012024-03-31RelatedPartyTransactionDomain455300192023-09-30RelatedPartyTransactionDomain455300192024-03-31RelatedPartyTransactionDomain455300192023-10-012024-03-31RelatedPartyTransactionDomain465300192023-09-30RelatedPartyTransactionDomain465300192024-03-31RelatedPartyTransactionDomain465300192023-10-012024-03-31RelatedPartyTransactionDomain475300192023-09-30RelatedPartyTransactionDomain475300192024-03-31RelatedPartyTransactionDomain475300192023-10-012024-03-31RelatedPartyTransactionDomain485300192023-09-30RelatedPartyTransactionDomain485300192024-03-31RelatedPartyTransactionDomain485300192023-10-012024-03-31RelatedPartyTransactionDomain495300192023-09-30RelatedPartyTransactionDomain495300192024-03-31RelatedPartyTransactionDomain495300192023-10-012024-03-31RelatedPartyTransactionDomain505300192023-09-30RelatedPartyTransactionDomain505300192024-03-31RelatedPartyTransactionDomain505300192023-10-012024-03-31RelatedPartyTransactionDomain515300192023-09-30RelatedPartyTransactionDomain515300192024-03-31RelatedPartyTransactionDomain515300192023-10-012024-03-31RelatedPartyTransactionDomain525300192023-09-30RelatedPartyTransactionDomain525300192024-03-31RelatedPartyTransactionDomain525300192023-10-012024-03-31RelatedPartyTransactionDomain535300192023-09-30RelatedPartyTransactionDomain535300192024-03-31RelatedPartyTransactionDomain535300192023-10-012024-03-31RelatedPartyTransactionDomain545300192023-09-30RelatedPartyTransactionDomain545300192024-03-31RelatedPartyTransactionDomain545300192023-10-012024-03-31RelatedPartyTransactionDomain555300192023-09-30RelatedPartyTransactionDomain555300192024-03-31RelatedPartyTransactionDomain555300192023-10-012024-03-31RelatedPartyTransactionDomain565300192023-09-30RelatedPartyTransactionDomain565300192024-03-31RelatedPartyTransactionDomain565300192023-10-012024-03-31RelatedPartyTransactionDomain575300192023-09-30RelatedPartyTransactionDomain575300192024-03-31RelatedPartyTransactionDomain575300192023-10-012024-03-31RelatedPartyTransactionDomain585300192023-09-30RelatedPartyTransactionDomain585300192024-03-31RelatedPartyTransactionDomain585300192023-10-012024-03-31RelatedPartyTransactionDomain595300192023-09-30RelatedPartyTransactionDomain595300192024-03-31RelatedPartyTransactionDomain595300192023-10-012024-03-31RelatedPartyTransactionDomain605300192023-09-30RelatedPartyTransactionDomain605300192024-03-31RelatedPartyTransactionDomain605300192023-10-012024-03-31RelatedPartyTransactionDomain615300192023-09-30RelatedPartyTransactionDomain615300192024-03-31RelatedPartyTransactionDomain615300192023-10-012024-03-31RelatedPartyTransactionDomain625300192023-09-30RelatedPartyTransactionDomain625300192024-03-31RelatedPartyTransactionDomain625300192023-10-012024-03-31RelatedPartyTransactionDomain635300192023-09-30RelatedPartyTransactionDomain635300192024-03-31RelatedPartyTransactionDomain635300192023-10-012024-03-31RelatedPartyTransactionDomain645300192023-09-30RelatedPartyTransactionDomain645300192024-03-31RelatedPartyTransactionDomain645300192023-10-012024-03-31RelatedPartyTransactionDomain655300192023-09-30RelatedPartyTransactionDomain655300192024-03-31RelatedPartyTransactionDomain655300192023-10-012024-03-31RelatedPartyTransactionDomain665300192023-09-30RelatedPartyTransactionDomain665300192024-03-31RelatedPartyTransactionDomain665300192023-10-012024-03-31RelatedPartyTransactionDomain675300192023-09-30RelatedPartyTransactionDomain675300192024-03-31RelatedPartyTransactionDomain675300192023-10-012024-03-31RelatedPartyTransactionDomain685300192023-09-30RelatedPartyTransactionDomain685300192024-03-31RelatedPartyTransactionDomain685300192023-10-012024-03-31RelatedPartyTransactionDomain695300192023-09-30RelatedPartyTransactionDomain695300192024-03-31RelatedPartyTransactionDomain695300192023-10-012024-03-31RelatedPartyTransactionDomain705300192023-09-30RelatedPartyTransactionDomain705300192024-03-31RelatedPartyTransactionDomain705300192023-10-012024-03-31RelatedPartyTransactionDomain715300192023-09-30RelatedPartyTransactionDomain715300192024-03-31RelatedPartyTransactionDomain715300192023-10-012024-03-31RelatedPartyTransactionDomain725300192023-09-30RelatedPartyTransactionDomain725300192024-03-31RelatedPartyTransactionDomain725300192023-10-012024-03-31RelatedPartyTransactionDomain735300192023-09-30RelatedPartyTransactionDomain735300192024-03-31RelatedPartyTransactionDomain735300192023-10-012024-03-31RelatedPartyTransactionDomain745300192023-09-30RelatedPartyTransactionDomain745300192024-03-31RelatedPartyTransactionDomain745300192023-10-012024-03-31RelatedPartyTransactionDomain755300192023-09-30RelatedPartyTransactionDomain755300192024-03-31RelatedPartyTransactionDomain755300192023-10-012024-03-31RelatedPartyTransactionDomain765300192023-09-30RelatedPartyTransactionDomain765300192024-03-31RelatedPartyTransactionDomain765300192023-10-012024-03-31RelatedPartyTransactionDomain775300192023-09-30RelatedPartyTransactionDomain775300192024-03-31RelatedPartyTransactionDomain775300192023-10-012024-03-31RelatedPartyTransactionDomain785300192023-09-30RelatedPartyTransactionDomain785300192024-03-31RelatedPartyTransactionDomain785300192023-10-012024-03-31RelatedPartyTransactionDomain795300192023-09-30RelatedPartyTransactionDomain795300192024-03-31RelatedPartyTransactionDomain795300192023-10-012024-03-31RelatedPartyTransactionDomain805300192023-09-30RelatedPartyTransactionDomain805300192024-03-31RelatedPartyTransactionDomain805300192023-10-012024-03-31RelatedPartyTransactionDomain815300192023-09-30RelatedPartyTransactionDomain815300192024-03-31RelatedPartyTransactionDomain815300192023-10-012024-03-31RelatedPartyTransactionDomain825300192023-09-30RelatedPartyTransactionDomain825300192024-03-31RelatedPartyTransactionDomain825300192023-10-012024-03-31RelatedPartyTransactionDomain835300192023-09-30RelatedPartyTransactionDomain835300192024-03-31RelatedPartyTransactionDomain835300192023-10-012024-03-31RelatedPartyTransactionDomain845300192023-09-30RelatedPartyTransactionDomain845300192024-03-31RelatedPartyTransactionDomain845300192023-10-012024-03-31RelatedPartyTransactionDomain855300192023-09-30RelatedPartyTransactionDomain855300192024-03-31RelatedPartyTransactionDomain855300192023-10-012024-03-31RelatedPartyTransactionDomain865300192023-09-30RelatedPartyTransactionDomain865300192024-03-31RelatedPartyTransactionDomain865300192023-10-012024-03-31RelatedPartyTransactionDomain875300192023-09-30RelatedPartyTransactionDomain875300192024-03-31RelatedPartyTransactionDomain875300192023-10-012024-03-31RelatedPartyTransactionDomain885300192023-09-30RelatedPartyTransactionDomain885300192024-03-31RelatedPartyTransactionDomain885300192023-10-012024-03-31RelatedPartyTransactionDomain895300192023-09-30RelatedPartyTransactionDomain895300192024-03-31RelatedPartyTransactionDomain895300192023-10-012024-03-31RelatedPartyTransactionDomain905300192023-09-30RelatedPartyTransactionDomain905300192024-03-31RelatedPartyTransactionDomain905300192023-10-012024-03-31RelatedPartyTransactionDomain915300192023-09-30RelatedPartyTransactionDomain915300192024-03-31RelatedPartyTransactionDomain915300192023-10-012024-03-31RelatedPartyTransactionDomain925300192023-09-30RelatedPartyTransactionDomain925300192024-03-31RelatedPartyTransactionDomain925300192023-10-012024-03-31RelatedPartyTransactionDomain935300192023-09-30RelatedPartyTransactionDomain935300192024-03-31RelatedPartyTransactionDomain935300192023-10-012024-03-31RelatedPartyTransactionDomain945300192023-09-30RelatedPartyTransactionDomain945300192024-03-31RelatedPartyTransactionDomain945300192023-10-012024-03-31RelatedPartyTransactionDomain955300192023-09-30RelatedPartyTransactionDomain955300192024-03-31RelatedPartyTransactionDomain955300192023-10-012024-03-31RelatedPartyTransactionDomain965300192023-09-30RelatedPartyTransactionDomain965300192024-03-31RelatedPartyTransactionDomain965300192023-10-012024-03-31RelatedPartyTransactionDomain975300192023-09-30RelatedPartyTransactionDomain975300192024-03-31RelatedPartyTransactionDomain975300192023-10-012024-03-31RelatedPartyTransactionDomain985300192023-09-30RelatedPartyTransactionDomain985300192024-03-31RelatedPartyTransactionDomain985300192023-10-012024-03-31RelatedPartyTransactionDomain995300192023-09-30RelatedPartyTransactionDomain995300192024-03-31RelatedPartyTransactionDomain995300192023-10-012024-03-31RelatedPartyTransactionDomain1005300192023-09-30RelatedPartyTransactionDomain1005300192024-03-31RelatedPartyTransactionDomain1005300192023-10-012024-03-31RelatedPartyTransactionDomain1015300192023-09-30RelatedPartyTransactionDomain1015300192024-03-31RelatedPartyTransactionDomain1015300192023-10-012024-03-31RelatedPartyTransactionDomain1025300192023-09-30RelatedPartyTransactionDomain1025300192024-03-31RelatedPartyTransactionDomain1025300192023-10-012024-03-31RelatedPartyTransactionDomain1035300192023-09-30RelatedPartyTransactionDomain1035300192024-03-31RelatedPartyTransactionDomain1035300192023-10-012024-03-31RelatedPartyTransactionDomain1045300192023-09-30RelatedPartyTransactionDomain1045300192024-03-31RelatedPartyTransactionDomain1045300192023-10-012024-03-31RelatedPartyTransactionDomain1055300192023-09-30RelatedPartyTransactionDomain1055300192024-03-31RelatedPartyTransactionDomain1055300192023-10-012024-03-31RelatedPartyTransactionDomain1065300192023-09-30RelatedPartyTransactionDomain1065300192024-03-31RelatedPartyTransactionDomain1065300192023-10-012024-03-31RelatedPartyTransactionDomain1075300192023-09-30RelatedPartyTransactionDomain1075300192024-03-31RelatedPartyTransactionDomain1075300192023-10-012024-03-31RelatedPartyTransactionDomain1085300192023-09-30RelatedPartyTransactionDomain1085300192024-03-31RelatedPartyTransactionDomain1085300192023-10-012024-03-31RelatedPartyTransactionDomain1095300192023-09-30RelatedPartyTransactionDomain1095300192024-03-31RelatedPartyTransactionDomain1095300192023-10-012024-03-31RelatedPartyTransactionDomain1105300192023-09-30RelatedPartyTransactionDomain1105300192024-03-31RelatedPartyTransactionDomain1105300192023-10-012024-03-31RelatedPartyTransactionDomain1115300192023-09-30RelatedPartyTransactionDomain1115300192024-03-31RelatedPartyTransactionDomain1115300192023-10-012024-03-31RelatedPartyTransactionDomain1125300192023-09-30RelatedPartyTransactionDomain1125300192024-03-31RelatedPartyTransactionDomain1125300192023-10-012024-03-31RelatedPartyTransactionDomain1135300192023-09-30RelatedPartyTransactionDomain1135300192024-03-31RelatedPartyTransactionDomain1135300192023-10-012024-03-31RelatedPartyTransactionDomain1145300192023-09-30RelatedPartyTransactionDomain1145300192024-03-31RelatedPartyTransactionDomain1145300192023-10-012024-03-31RelatedPartyTransactionDomain1155300192023-09-30RelatedPartyTransactionDomain1155300192024-03-31RelatedPartyTransactionDomain1155300192023-10-012024-03-31RelatedPartyTransactionDomain1165300192023-09-30RelatedPartyTransactionDomain1165300192024-03-31RelatedPartyTransactionDomain1165300192023-10-012024-03-31RelatedPartyTransactionDomain1175300192023-09-30RelatedPartyTransactionDomain1175300192024-03-31RelatedPartyTransactionDomain1175300192023-10-012024-03-31RelatedPartyTransactionDomain1185300192023-09-30RelatedPartyTransactionDomain1185300192024-03-31RelatedPartyTransactionDomain1185300192023-10-012024-03-31RelatedPartyTransactionDomain1195300192023-09-30RelatedPartyTransactionDomain1195300192024-03-31RelatedPartyTransactionDomain1195300192023-10-012024-03-31RelatedPartyTransactionDomain1205300192023-09-30RelatedPartyTransactionDomain1205300192024-03-31RelatedPartyTransactionDomain1205300192023-10-012024-03-31RelatedPartyTransactionDomain1215300192023-09-30RelatedPartyTransactionDomain1215300192024-03-31RelatedPartyTransactionDomain1215300192023-10-012024-03-31RelatedPartyTransactionDomain1225300192023-09-30RelatedPartyTransactionDomain1225300192024-03-31RelatedPartyTransactionDomain1225300192023-10-012024-03-31RelatedPartyTransactionDomain1235300192023-09-30RelatedPartyTransactionDomain1235300192024-03-31RelatedPartyTransactionDomain1235300192023-10-012024-03-31RelatedPartyTransactionDomain1245300192023-09-30RelatedPartyTransactionDomain1245300192024-03-31RelatedPartyTransactionDomain1245300192023-10-012024-03-31RelatedPartyTransactionDomain1255300192023-09-30RelatedPartyTransactionDomain1255300192024-03-31RelatedPartyTransactionDomain1255300192023-10-012024-03-31RelatedPartyTransactionDomain1265300192023-09-30RelatedPartyTransactionDomain1265300192024-03-31RelatedPartyTransactionDomain1265300192023-10-012024-03-31RelatedPartyTransactionDomain1275300192023-09-30RelatedPartyTransactionDomain1275300192024-03-31RelatedPartyTransactionDomain1275300192023-10-012024-03-31RelatedPartyTransactionDomain1285300192023-09-30RelatedPartyTransactionDomain1285300192024-03-31RelatedPartyTransactionDomain1285300192023-10-012024-03-31RelatedPartyTransactionDomain1295300192023-09-30RelatedPartyTransactionDomain1295300192024-03-31RelatedPartyTransactionDomain1295300192023-10-012024-03-31RelatedPartyTransactionDomain1305300192023-09-30RelatedPartyTransactionDomain1305300192024-03-31RelatedPartyTransactionDomain1305300192023-10-012024-03-31RelatedPartyTransactionDomain1315300192023-09-30RelatedPartyTransactionDomain1315300192024-03-31RelatedPartyTransactionDomain1315300192023-10-012024-03-31RelatedPartyTransactionDomain1325300192023-09-30RelatedPartyTransactionDomain1325300192024-03-31RelatedPartyTransactionDomain1325300192023-10-012024-03-31RelatedPartyTransactionDomain1335300192023-09-30RelatedPartyTransactionDomain1335300192024-03-31RelatedPartyTransactionDomain1335300192023-10-012024-03-31RelatedPartyTransactionDomain1345300192023-09-30RelatedPartyTransactionDomain1345300192024-03-31RelatedPartyTransactionDomain1345300192023-10-012024-03-31RelatedPartyTransactionDomain1355300192023-09-30RelatedPartyTransactionDomain1355300192024-03-31RelatedPartyTransactionDomain1355300192023-10-012024-03-31RelatedPartyTransactionDomain1365300192023-09-30RelatedPartyTransactionDomain1365300192024-03-31RelatedPartyTransactionDomain1365300192023-10-012024-03-31RelatedPartyTransactionDomain1375300192023-09-30RelatedPartyTransactionDomain1375300192024-03-31RelatedPartyTransactionDomain1375300192023-10-012024-03-31RelatedPartyTransactionDomain1385300192023-09-30RelatedPartyTransactionDomain1385300192024-03-31RelatedPartyTransactionDomain1385300192023-10-012024-03-31RelatedPartyTransactionDomain1395300192023-09-30RelatedPartyTransactionDomain1395300192024-03-31RelatedPartyTransactionDomain1395300192023-10-012024-03-31RelatedPartyTransactionDomain1405300192023-09-30RelatedPartyTransactionDomain1405300192024-03-31RelatedPartyTransactionDomain1405300192023-10-012024-03-31RelatedPartyTransactionDomain1415300192023-09-30RelatedPartyTransactionDomain1415300192024-03-31RelatedPartyTransactionDomain1415300192023-10-012024-03-31RelatedPartyTransactionDomain1425300192023-09-30RelatedPartyTransactionDomain1425300192024-03-31RelatedPartyTransactionDomain1425300192023-10-012024-03-31RelatedPartyTransactionDomain1435300192023-09-30RelatedPartyTransactionDomain1435300192024-03-31RelatedPartyTransactionDomain1435300192023-10-012024-03-31RelatedPartyTransactionDomain1445300192023-09-30RelatedPartyTransactionDomain1445300192024-03-31RelatedPartyTransactionDomain1445300192023-10-012024-03-31RelatedPartyTransactionDomain1455300192023-09-30RelatedPartyTransactionDomain1455300192024-03-31RelatedPartyTransactionDomain1455300192023-10-012024-03-31RelatedPartyTransactionDomain1465300192023-09-30RelatedPartyTransactionDomain1465300192024-03-31RelatedPartyTransactionDomain1465300192023-10-012024-03-31RelatedPartyTransactionDomain1475300192023-09-30RelatedPartyTransactionDomain1475300192024-03-31RelatedPartyTransactionDomain1475300192023-10-012024-03-31RelatedPartyTransactionDomain1485300192023-09-30RelatedPartyTransactionDomain1485300192024-03-31RelatedPartyTransactionDomain1485300192023-10-012024-03-31RelatedPartyTransactionDomain1495300192023-09-30RelatedPartyTransactionDomain1495300192024-03-31RelatedPartyTransactionDomain1495300192023-10-012024-03-31RelatedPartyTransactionDomain1505300192023-09-30RelatedPartyTransactionDomain1505300192024-03-31RelatedPartyTransactionDomain1505300192023-10-012024-03-31RelatedPartyTransactionDomain1515300192023-09-30RelatedPartyTransactionDomain1515300192024-03-31RelatedPartyTransactionDomain1515300192023-10-012024-03-31RelatedPartyTransactionDomain1525300192023-09-30RelatedPartyTransactionDomain1525300192024-03-31RelatedPartyTransactionDomain1525300192023-10-012024-03-31RelatedPartyTransactionDomain1535300192023-09-30RelatedPartyTransactionDomain1535300192024-03-31RelatedPartyTransactionDomain1535300192023-10-012024-03-31RelatedPartyTransactionDomain1545300192023-09-30RelatedPartyTransactionDomain1545300192024-03-31RelatedPartyTransactionDomain1545300192023-10-012024-03-31RelatedPartyTransactionDomain1555300192023-09-30RelatedPartyTransactionDomain1555300192024-03-31RelatedPartyTransactionDomain1555300192023-10-012024-03-31RelatedPartyTransactionDomain1565300192023-09-30RelatedPartyTransactionDomain1565300192024-03-31RelatedPartyTransactionDomain1565300192023-10-012024-03-31RelatedPartyTransactionDomain1575300192023-09-30RelatedPartyTransactionDomain1575300192024-03-31RelatedPartyTransactionDomain1575300192023-10-012024-03-31RelatedPartyTransactionDomain1585300192023-09-30RelatedPartyTransactionDomain1585300192024-03-31RelatedPartyTransactionDomain1585300192023-10-012024-03-31RelatedPartyTransactionDomain1595300192023-09-30RelatedPartyTransactionDomain1595300192024-03-31RelatedPartyTransactionDomain1595300192023-10-012024-03-31RelatedPartyTransactionDomain1605300192023-09-30RelatedPartyTransactionDomain1605300192024-03-31RelatedPartyTransactionDomain1605300192023-10-012024-03-31RelatedPartyTransactionDomain1615300192023-09-30RelatedPartyTransactionDomain1615300192024-03-31RelatedPartyTransactionDomain1615300192023-10-012024-03-31RelatedPartyTransactionDomain1625300192023-09-30RelatedPartyTransactionDomain1625300192024-03-31RelatedPartyTransactionDomain1625300192023-10-012024-03-31RelatedPartyTransactionDomain1635300192023-09-30RelatedPartyTransactionDomain1635300192024-03-31RelatedPartyTransactionDomain1635300192023-10-012024-03-31RelatedPartyTransactionDomain1645300192023-09-30RelatedPartyTransactionDomain1645300192024-03-31RelatedPartyTransactionDomain1645300192023-10-012024-03-31RelatedPartyTransactionDomain1655300192023-09-30RelatedPartyTransactionDomain1655300192024-03-31RelatedPartyTransactionDomain1655300192023-10-012024-03-31RelatedPartyTransactionDomain1665300192023-09-30RelatedPartyTransactionDomain1665300192024-03-31RelatedPartyTransactionDomain1665300192023-10-012024-03-31RelatedPartyTransactionDomain1675300192023-09-30RelatedPartyTransactionDomain1675300192024-03-31RelatedPartyTransactionDomain1675300192023-10-012024-03-31RelatedPartyTransactionDomain1685300192023-09-30RelatedPartyTransactionDomain1685300192024-03-31RelatedPartyTransactionDomain1685300192023-10-012024-03-31RelatedPartyTransactionDomain1695300192023-09-30RelatedPartyTransactionDomain1695300192024-03-31RelatedPartyTransactionDomain1695300192023-10-012024-03-31RelatedPartyTransactionDomain1705300192023-09-30RelatedPartyTransactionDomain1705300192024-03-31RelatedPartyTransactionDomain1705300192023-10-012024-03-31RelatedPartyTransactionDomain1715300192023-09-30RelatedPartyTransactionDomain1715300192024-03-31RelatedPartyTransactionDomain1715300192023-10-012024-03-31RelatedPartyTransactionDomain1725300192023-09-30RelatedPartyTransactionDomain1725300192024-03-31RelatedPartyTransactionDomain1725300192023-10-012024-03-31RelatedPartyTransactionDomain1735300192023-09-30RelatedPartyTransactionDomain1735300192024-03-31RelatedPartyTransactionDomain1735300192023-10-012024-03-31RelatedPartyTransactionDomain1745300192023-09-30RelatedPartyTransactionDomain1745300192024-03-31RelatedPartyTransactionDomain1745300192023-10-012024-03-31RelatedPartyTransactionDomain1755300192023-09-30RelatedPartyTransactionDomain1755300192024-03-31RelatedPartyTransactionDomain1755300192023-10-012024-03-31RelatedPartyTransactionDomain1765300192023-09-30RelatedPartyTransactionDomain1765300192024-03-31RelatedPartyTransactionDomain1765300192023-10-012024-03-31RelatedPartyTransactionDomain1775300192023-09-30RelatedPartyTransactionDomain1775300192024-03-31RelatedPartyTransactionDomain1775300192023-10-012024-03-31RelatedPartyTransactionDomain1785300192023-09-30RelatedPartyTransactionDomain1785300192024-03-31RelatedPartyTransactionDomain1785300192023-10-012024-03-31RelatedPartyTransactionDomain1795300192023-09-30RelatedPartyTransactionDomain1795300192024-03-31RelatedPartyTransactionDomain1795300192023-10-012024-03-31RelatedPartyTransactionDomain1805300192023-09-30RelatedPartyTransactionDomain1805300192024-03-31RelatedPartyTransactionDomain1805300192023-10-012024-03-31RelatedPartyTransactionDomain1815300192023-09-30RelatedPartyTransactionDomain1815300192024-03-31RelatedPartyTransactionDomain1815300192023-10-012024-03-31RelatedPartyTransactionDomain1825300192023-09-30RelatedPartyTransactionDomain1825300192024-03-31RelatedPartyTransactionDomain1825300192023-10-012024-03-31RelatedPartyTransactionDomain1835300192023-09-30RelatedPartyTransactionDomain1835300192024-03-31RelatedPartyTransactionDomain1835300192023-10-012024-03-31RelatedPartyTransactionDomain1845300192023-09-30RelatedPartyTransactionDomain1845300192024-03-31RelatedPartyTransactionDomain1845300192023-10-012024-03-31RelatedPartyTransactionDomain1855300192023-09-30RelatedPartyTransactionDomain1855300192024-03-31RelatedPartyTransactionDomain1855300192023-10-012024-03-31RelatedPartyTransactionDomain1865300192023-09-30RelatedPartyTransactionDomain1865300192024-03-31RelatedPartyTransactionDomain1865300192023-10-012024-03-31RelatedPartyTransactionDomain1875300192023-09-30RelatedPartyTransactionDomain1875300192024-03-31RelatedPartyTransactionDomain1875300192023-10-012024-03-31RelatedPartyTransactionDomain1885300192023-09-30RelatedPartyTransactionDomain1885300192024-03-31RelatedPartyTransactionDomain1885300192023-10-012024-03-31RelatedPartyTransactionDomain1895300192023-09-30RelatedPartyTransactionDomain1895300192024-03-31RelatedPartyTransactionDomain1895300192023-10-012024-03-31RelatedPartyTransactionDomain1905300192023-09-30RelatedPartyTransactionDomain1905300192024-03-31RelatedPartyTransactionDomain1905300192023-10-012024-03-31RelatedPartyTransactionDomain1915300192023-09-30RelatedPartyTransactionDomain1915300192024-03-31RelatedPartyTransactionDomain1915300192023-10-012024-03-31RelatedPartyTransactionDomain1925300192023-09-30RelatedPartyTransactionDomain1925300192024-03-31RelatedPartyTransactionDomain1925300192023-10-012024-03-31RelatedPartyTransactionDomain1935300192023-09-30RelatedPartyTransactionDomain1935300192024-03-31RelatedPartyTransactionDomain1935300192023-10-012024-03-31RelatedPartyTransactionDomain1945300192023-09-30RelatedPartyTransactionDomain1945300192024-03-31RelatedPartyTransactionDomain1945300192023-10-012024-03-31RelatedPartyTransactionDomain1955300192023-09-30RelatedPartyTransactionDomain1955300192024-03-31RelatedPartyTransactionDomain1955300192023-10-012024-03-31RelatedPartyTransactionDomain1965300192023-09-30RelatedPartyTransactionDomain1965300192024-03-31RelatedPartyTransactionDomain1965300192023-10-012024-03-31RelatedPartyTransactionDomain1975300192023-09-30RelatedPartyTransactionDomain1975300192024-03-31RelatedPartyTransactionDomain1975300192023-10-012024-03-31RelatedPartyTransactionDomain1985300192023-09-30RelatedPartyTransactionDomain1985300192024-03-31RelatedPartyTransactionDomain1985300192023-10-012024-03-31RelatedPartyTransactionDomain1995300192023-09-30RelatedPartyTransactionDomain1995300192024-03-31RelatedPartyTransactionDomain1995300192023-10-012024-03-31RelatedPartyTransactionDomain2005300192023-09-30RelatedPartyTransactionDomain2005300192024-03-31RelatedPartyTransactionDomain2005300192023-10-012024-03-31RelatedPartyTransactionDomain2015300192023-09-30RelatedPartyTransactionDomain2015300192024-03-31RelatedPartyTransactionDomain2015300192023-10-012024-03-31RelatedPartyTransactionDomain2025300192023-09-30RelatedPartyTransactionDomain2025300192024-03-31RelatedPartyTransactionDomain2025300192023-10-012024-03-31RelatedPartyTransactionDomain2035300192023-09-30RelatedPartyTransactionDomain2035300192024-03-31RelatedPartyTransactionDomain2035300192023-10-012024-03-31RelatedPartyTransactionDomain2045300192023-09-30RelatedPartyTransactionDomain2045300192024-03-31RelatedPartyTransactionDomain2045300192023-10-012024-03-31RelatedPartyTransactionDomain2055300192023-09-30RelatedPartyTransactionDomain2055300192024-03-31RelatedPartyTransactionDomain2055300192023-10-012024-03-31RelatedPartyTransactionDomain2065300192023-09-30RelatedPartyTransactionDomain2065300192024-03-31RelatedPartyTransactionDomain2065300192023-10-012024-03-31RelatedPartyTransactionDomain2075300192023-09-30RelatedPartyTransactionDomain2075300192024-03-31RelatedPartyTransactionDomain2075300192023-10-012024-03-31RelatedPartyTransactionDomain2085300192023-09-30RelatedPartyTransactionDomain2085300192024-03-31RelatedPartyTransactionDomain2085300192023-10-012024-03-31RelatedPartyTransactionDomain2095300192023-09-30RelatedPartyTransactionDomain2095300192024-03-31RelatedPartyTransactionDomain2095300192023-10-012024-03-31RelatedPartyTransactionDomain2105300192023-09-30RelatedPartyTransactionDomain2105300192024-03-31RelatedPartyTransactionDomain2105300192023-10-012024-03-31RelatedPartyTransactionDomain2115300192023-09-30RelatedPartyTransactionDomain2115300192024-03-31RelatedPartyTransactionDomain2115300192023-10-012024-03-31RelatedPartyTransactionDomain2125300192023-09-30RelatedPartyTransactionDomain2125300192024-03-31RelatedPartyTransactionDomain2125300192023-10-012024-03-31RelatedPartyTransactionDomain2135300192023-09-30RelatedPartyTransactionDomain2135300192024-03-31RelatedPartyTransactionDomain2135300192023-10-012024-03-31RelatedPartyTransactionDomain2145300192023-09-30RelatedPartyTransactionDomain2145300192024-03-31RelatedPartyTransactionDomain2145300192023-10-012024-03-31RelatedPartyTransactionDomain2155300192023-09-30RelatedPartyTransactionDomain2155300192024-03-31RelatedPartyTransactionDomain2155300192023-10-012024-03-31RelatedPartyTransactionDomain2165300192023-09-30RelatedPartyTransactionDomain2165300192024-03-31RelatedPartyTransactionDomain2165300192023-10-012024-03-31RelatedPartyTransactionDomain2175300192023-09-30RelatedPartyTransactionDomain2175300192024-03-31RelatedPartyTransactionDomain2175300192023-10-012024-03-31RelatedPartyTransactionDomain2185300192023-09-30RelatedPartyTransactionDomain2185300192024-03-31RelatedPartyTransactionDomain2185300192023-10-012024-03-31RelatedPartyTransactionDomain2195300192023-09-30RelatedPartyTransactionDomain2195300192024-03-31RelatedPartyTransactionDomain2195300192023-10-012024-03-31RelatedPartyTransactionDomain2205300192023-09-30RelatedPartyTransactionDomain2205300192024-03-31RelatedPartyTransactionDomain2205300192023-10-012024-03-31RelatedPartyTransactionDomain2215300192023-09-30RelatedPartyTransactionDomain2215300192024-03-31RelatedPartyTransactionDomain2215300192023-10-012024-03-31RelatedPartyTransactionDomain2225300192023-09-30RelatedPartyTransactionDomain2225300192024-03-31RelatedPartyTransactionDomain2225300192023-10-012024-03-31RelatedPartyTransactionDomain2235300192023-09-30RelatedPartyTransactionDomain2235300192024-03-31RelatedPartyTransactionDomain2235300192023-10-012024-03-31RelatedPartyTransactionDomain2245300192023-09-30RelatedPartyTransactionDomain2245300192024-03-31RelatedPartyTransactionDomain2245300192023-10-012024-03-31RelatedPartyTransactionDomain2255300192023-09-30RelatedPartyTransactionDomain2255300192024-03-31RelatedPartyTransactionDomain2255300192023-10-012024-03-31RelatedPartyTransactionDomain2265300192023-09-30RelatedPartyTransactionDomain2265300192024-03-31RelatedPartyTransactionDomain2265300192023-10-012024-03-31RelatedPartyTransactionDomain2275300192023-09-30RelatedPartyTransactionDomain2275300192024-03-31RelatedPartyTransactionDomain2275300192023-10-012024-03-31RelatedPartyTransactionDomain2285300192023-09-30RelatedPartyTransactionDomain2285300192024-03-31RelatedPartyTransactionDomain2285300192023-10-012024-03-31RelatedPartyTransactionDomain2295300192023-09-30RelatedPartyTransactionDomain2295300192024-03-31RelatedPartyTransactionDomain2295300192023-10-012024-03-31RelatedPartyTransactionDomain2305300192023-09-30RelatedPartyTransactionDomain2305300192024-03-31RelatedPartyTransactionDomain2305300192023-10-012024-03-31RelatedPartyTransactionDomain2315300192023-09-30RelatedPartyTransactionDomain2315300192024-03-31RelatedPartyTransactionDomain2315300192023-10-012024-03-31RelatedPartyTransactionDomain2325300192023-09-30RelatedPartyTransactionDomain2325300192024-03-31RelatedPartyTransactionDomain2325300192023-10-012024-03-31RelatedPartyTransactionDomain2335300192023-09-30RelatedPartyTransactionDomain2335300192024-03-31RelatedPartyTransactionDomain2335300192023-10-012024-03-31RelatedPartyTransactionDomain2345300192023-09-30RelatedPartyTransactionDomain2345300192024-03-31RelatedPartyTransactionDomain2345300192023-10-012024-03-31RelatedPartyTransactionDomain2355300192023-09-30RelatedPartyTransactionDomain2355300192024-03-31RelatedPartyTransactionDomain2355300192023-10-012024-03-31RelatedPartyTransactionDomain2365300192023-09-30RelatedPartyTransactionDomain2365300192024-03-31RelatedPartyTransactionDomain2365300192023-10-012024-03-31RelatedPartyTransactionDomain2375300192023-09-30RelatedPartyTransactionDomain2375300192024-03-31RelatedPartyTransactionDomain2375300192023-10-012024-03-31RelatedPartyTransactionDomain2385300192023-09-30RelatedPartyTransactionDomain2385300192024-03-31RelatedPartyTransactionDomain2385300192023-10-012024-03-31RelatedPartyTransactionDomain2395300192023-09-30RelatedPartyTransactionDomain2395300192024-03-31RelatedPartyTransactionDomain2395300192023-10-012024-03-31RelatedPartyTransactionDomain2405300192023-09-30RelatedPartyTransactionDomain2405300192024-03-31RelatedPartyTransactionDomain2405300192023-10-012024-03-31RelatedPartyTransactionDomain2415300192023-09-30RelatedPartyTransactionDomain2415300192024-03-31RelatedPartyTransactionDomain2415300192023-10-012024-03-31RelatedPartyTransactionDomain2425300192023-09-30RelatedPartyTransactionDomain2425300192024-03-31RelatedPartyTransactionDomain2425300192023-10-012024-03-31RelatedPartyTransactionDomain2435300192023-09-30RelatedPartyTransactionDomain2435300192024-03-31RelatedPartyTransactionDomain2435300192023-10-012024-03-31RelatedPartyTransactionDomain2445300192023-09-30RelatedPartyTransactionDomain2445300192024-03-31RelatedPartyTransactionDomain2445300192023-10-012024-03-31RelatedPartyTransactionDomain2455300192023-09-30RelatedPartyTransactionDomain2455300192024-03-31RelatedPartyTransactionDomain2455300192023-10-012024-03-31RelatedPartyTransactionDomain2465300192023-09-30RelatedPartyTransactionDomain2465300192024-03-31RelatedPartyTransactionDomain2465300192023-10-012024-03-31RelatedPartyTransactionDomain2475300192023-09-30RelatedPartyTransactionDomain2475300192024-03-31RelatedPartyTransactionDomain2475300192023-10-012024-03-31RelatedPartyTransactionDomain2485300192023-09-30RelatedPartyTransactionDomain2485300192024-03-31RelatedPartyTransactionDomain2485300192023-10-012024-03-31RelatedPartyTransactionDomain2495300192023-09-30RelatedPartyTransactionDomain2495300192024-03-31RelatedPartyTransactionDomain2495300192023-10-012024-03-31RelatedPartyTransactionDomain2505300192023-09-30RelatedPartyTransactionDomain2505300192024-03-31RelatedPartyTransactionDomain2505300192023-10-012024-03-31RelatedPartyTransactionDomain2515300192023-09-30RelatedPartyTransactionDomain2515300192024-03-31RelatedPartyTransactionDomain2515300192023-10-012024-03-31RelatedPartyTransactionDomain2525300192023-09-30RelatedPartyTransactionDomain2525300192024-03-31RelatedPartyTransactionDomain2525300192023-10-012024-03-31RelatedPartyTransactionDomain2535300192023-09-30RelatedPartyTransactionDomain2535300192024-03-31RelatedPartyTransactionDomain2535300192023-10-012024-03-31RelatedPartyTransactionDomain2545300192023-09-30RelatedPartyTransactionDomain2545300192024-03-31RelatedPartyTransactionDomain2545300192023-10-012024-03-31RelatedPartyTransactionDomain2555300192023-09-30RelatedPartyTransactionDomain2555300192024-03-31RelatedPartyTransactionDomain2555300192023-10-012024-03-31RelatedPartyTransactionDomain2565300192023-09-30RelatedPartyTransactionDomain2565300192024-03-31RelatedPartyTransactionDomain2565300192023-10-012024-03-31RelatedPartyTransactionDomain2575300192023-09-30RelatedPartyTransactionDomain2575300192024-03-31RelatedPartyTransactionDomain2575300192023-10-012024-03-31RelatedPartyTransactionDomain2585300192023-09-30RelatedPartyTransactionDomain2585300192024-03-31RelatedPartyTransactionDomain2585300192023-10-012024-03-31RelatedPartyTransactionDomain2595300192023-09-30RelatedPartyTransactionDomain2595300192024-03-31RelatedPartyTransactionDomain2595300192023-10-012024-03-31RelatedPartyTransactionDomain2605300192023-09-30RelatedPartyTransactionDomain2605300192024-03-31RelatedPartyTransactionDomain2605300192023-10-012024-03-31RelatedPartyTransactionDomain2615300192023-09-30RelatedPartyTransactionDomain2615300192024-03-31RelatedPartyTransactionDomain2615300192023-10-012024-03-31RelatedPartyTransactionDomain2625300192023-09-30RelatedPartyTransactionDomain2625300192024-03-31RelatedPartyTransactionDomain2625300192023-10-012024-03-31RelatedPartyTransactionDomain2635300192023-09-30RelatedPartyTransactionDomain2635300192024-03-31RelatedPartyTransactionDomain2635300192023-10-012024-03-31RelatedPartyTransactionDomain2645300192023-09-30RelatedPartyTransactionDomain2645300192024-03-31RelatedPartyTransactionDomain2645300192023-10-012024-03-31RelatedPartyTransactionDomain2655300192023-09-30RelatedPartyTransactionDomain2655300192024-03-31RelatedPartyTransactionDomain2655300192023-10-012024-03-31RelatedPartyTransactionDomain2665300192023-09-30RelatedPartyTransactionDomain2665300192024-03-31RelatedPartyTransactionDomain2665300192023-10-012024-03-31RelatedPartyTransactionDomain2675300192023-09-30RelatedPartyTransactionDomain2675300192024-03-31RelatedPartyTransactionDomain2675300192023-10-012024-03-31RelatedPartyTransactionDomain2685300192023-09-30RelatedPartyTransactionDomain2685300192024-03-31RelatedPartyTransactionDomain2685300192023-10-012024-03-31RelatedPartyTransactionDomain2695300192023-09-30RelatedPartyTransactionDomain2695300192024-03-31RelatedPartyTransactionDomain2695300192023-10-012024-03-31RelatedPartyTransactionDomain2705300192023-09-30RelatedPartyTransactionDomain2705300192024-03-31RelatedPartyTransactionDomain2705300192023-10-012024-03-31RelatedPartyTransactionDomain2715300192023-09-30RelatedPartyTransactionDomain2715300192024-03-31RelatedPartyTransactionDomain2715300192023-10-012024-03-31RelatedPartyTransactionDomain2725300192023-09-30RelatedPartyTransactionDomain2725300192024-03-31RelatedPartyTransactionDomain2725300192023-10-012024-03-31RelatedPartyTransactionDomain2735300192023-09-30RelatedPartyTransactionDomain2735300192024-03-31RelatedPartyTransactionDomain2735300192023-10-012024-03-31RelatedPartyTransactionDomain2745300192023-09-30RelatedPartyTransactionDomain2745300192024-03-31RelatedPartyTransactionDomain2745300192023-10-012024-03-31RelatedPartyTransactionDomain2755300192023-09-30RelatedPartyTransactionDomain2755300192024-03-31RelatedPartyTransactionDomain2755300192023-10-012024-03-31RelatedPartyTransactionDomain2765300192023-09-30RelatedPartyTransactionDomain2765300192024-03-31RelatedPartyTransactionDomain2765300192023-10-012024-03-31RelatedPartyTransactionDomain2775300192023-09-30RelatedPartyTransactionDomain2775300192024-03-31RelatedPartyTransactionDomain2775300192023-10-012024-03-31RelatedPartyTransactionDomain2785300192023-09-30RelatedPartyTransactionDomain2785300192024-03-31RelatedPartyTransactionDomain2785300192023-10-012024-03-31RelatedPartyTransactionDomain2795300192023-09-30RelatedPartyTransactionDomain2795300192024-03-31RelatedPartyTransactionDomain2795300192023-10-012024-03-31RelatedPartyTransactionDomain2805300192023-09-30RelatedPartyTransactionDomain2805300192024-03-31RelatedPartyTransactionDomain2805300192023-10-012024-03-31RelatedPartyTransactionDomain2815300192023-09-30RelatedPartyTransactionDomain2815300192024-03-31RelatedPartyTransactionDomain2815300192023-10-012024-03-31RelatedPartyTransactionDomain2825300192023-09-30RelatedPartyTransactionDomain2825300192024-03-31RelatedPartyTransactionDomain2825300192023-10-012024-03-31RelatedPartyTransactionDomain2835300192023-09-30RelatedPartyTransactionDomain2835300192024-03-31RelatedPartyTransactionDomain2835300192023-10-012024-03-31RelatedPartyTransactionDomain2845300192023-09-30RelatedPartyTransactionDomain2845300192024-03-31RelatedPartyTransactionDomain2845300192023-10-012024-03-31RelatedPartyTransactionDomain2855300192023-09-30RelatedPartyTransactionDomain2855300192024-03-31RelatedPartyTransactionDomain2855300192023-10-012024-03-31RelatedPartyTransactionDomain2865300192023-09-30RelatedPartyTransactionDomain2865300192024-03-31RelatedPartyTransactionDomain2865300192023-10-012024-03-31RelatedPartyTransactionDomain2875300192023-09-30RelatedPartyTransactionDomain2875300192024-03-31RelatedPartyTransactionDomain2875300192023-10-012024-03-31RelatedPartyTransactionDomain2885300192023-09-30RelatedPartyTransactionDomain2885300192024-03-31RelatedPartyTransactionDomain2885300192023-10-012024-03-31RelatedPartyTransactionDomain2895300192023-09-30RelatedPartyTransactionDomain2895300192024-03-31RelatedPartyTransactionDomain2895300192023-10-012024-03-31RelatedPartyTransactionDomain2905300192023-09-30RelatedPartyTransactionDomain2905300192024-03-31RelatedPartyTransactionDomain2905300192023-10-012024-03-31RelatedPartyTransactionDomain2915300192023-09-30RelatedPartyTransactionDomain2915300192024-03-31RelatedPartyTransactionDomain2915300192023-10-012024-03-31RelatedPartyTransactionDomain2925300192023-09-30RelatedPartyTransactionDomain2925300192024-03-31RelatedPartyTransactionDomain2925300192023-10-012024-03-31RelatedPartyTransactionDomain2935300192023-09-30RelatedPartyTransactionDomain2935300192024-03-31RelatedPartyTransactionDomain2935300192023-10-012024-03-31RelatedPartyTransactionDomain2945300192023-09-30RelatedPartyTransactionDomain2945300192024-03-31RelatedPartyTransactionDomain2945300192023-10-012024-03-31RelatedPartyTransactionDomain2955300192023-09-30RelatedPartyTransactionDomain2955300192024-03-31RelatedPartyTransactionDomain2955300192023-10-012024-03-31RelatedPartyTransactionDomain2965300192023-09-30RelatedPartyTransactionDomain2965300192024-03-31RelatedPartyTransactionDomain2965300192023-10-012024-03-31RelatedPartyTransactionDomain2975300192023-09-30RelatedPartyTransactionDomain2975300192024-03-31RelatedPartyTransactionDomain2975300192023-10-012024-03-31RelatedPartyTransactionDomain2985300192023-09-30RelatedPartyTransactionDomain2985300192024-03-31RelatedPartyTransactionDomain2985300192023-10-012024-03-31RelatedPartyTransactionDomain2995300192023-09-30RelatedPartyTransactionDomain2995300192024-03-31RelatedPartyTransactionDomain2995300192023-10-012024-03-31RelatedPartyTransactionDomain3005300192023-09-30RelatedPartyTransactionDomain3005300192024-03-31RelatedPartyTransactionDomain3005300192023-10-012024-03-31RelatedPartyTransactionDomain3015300192023-09-30RelatedPartyTransactionDomain3015300192024-03-31RelatedPartyTransactionDomain3015300192023-10-012024-03-31RelatedPartyTransactionDomain3025300192023-09-30RelatedPartyTransactionDomain3025300192024-03-31RelatedPartyTransactionDomain3025300192023-10-012024-03-31RelatedPartyTransactionDomain3035300192023-09-30RelatedPartyTransactionDomain3035300192024-03-31RelatedPartyTransactionDomain3035300192023-10-012024-03-31RelatedPartyTransactionDomain3045300192023-09-30RelatedPartyTransactionDomain3045300192024-03-31RelatedPartyTransactionDomain3045300192023-10-012024-03-31RelatedPartyTransactionDomain3055300192023-09-30RelatedPartyTransactionDomain3055300192024-03-31RelatedPartyTransactionDomain3055300192023-10-012024-03-31RelatedPartyTransactionDomain3065300192023-09-30RelatedPartyTransactionDomain3065300192024-03-31RelatedPartyTransactionDomain3065300192023-10-012024-03-31RelatedPartyTransactionDomain3075300192023-09-30RelatedPartyTransactionDomain3075300192024-03-31RelatedPartyTransactionDomain3075300192023-10-012024-03-31RelatedPartyTransactionDomain3085300192023-09-30RelatedPartyTransactionDomain3085300192024-03-31RelatedPartyTransactionDomain3085300192023-10-012024-03-31RelatedPartyTransactionDomain3095300192023-09-30RelatedPartyTransactionDomain3095300192024-03-31RelatedPartyTransactionDomain3095300192023-10-012024-03-31RelatedPartyTransactionDomain3105300192023-09-30RelatedPartyTransactionDomain3105300192024-03-31RelatedPartyTransactionDomain3105300192023-10-012024-03-31RelatedPartyTransactionDomain3115300192023-09-30RelatedPartyTransactionDomain3115300192024-03-31RelatedPartyTransactionDomain3115300192023-10-012024-03-31RelatedPartyTransactionDomain3125300192023-09-30RelatedPartyTransactionDomain3125300192024-03-31RelatedPartyTransactionDomain3125300192023-10-012024-03-31RelatedPartyTransactionDomain3135300192023-09-30RelatedPartyTransactionDomain3135300192024-03-31RelatedPartyTransactionDomain3135300192023-10-012024-03-31RelatedPartyTransactionDomain3145300192023-09-30RelatedPartyTransactionDomain3145300192024-03-31RelatedPartyTransactionDomain3145300192023-10-012024-03-31RelatedPartyTransactionDomain3155300192023-09-30RelatedPartyTransactionDomain3155300192024-03-31RelatedPartyTransactionDomain3155300192023-10-012024-03-31RelatedPartyTransactionDomain3165300192023-09-30RelatedPartyTransactionDomain3165300192024-03-31RelatedPartyTransactionDomain3165300192023-10-012024-03-31RelatedPartyTransactionDomain3175300192023-09-30RelatedPartyTransactionDomain3175300192024-03-31RelatedPartyTransactionDomain3175300192023-10-012024-03-31RelatedPartyTransactionDomain3185300192023-09-30RelatedPartyTransactionDomain3185300192024-03-31RelatedPartyTransactionDomain3185300192023-10-012024-03-31RelatedPartyTransactionDomain3195300192023-09-30RelatedPartyTransactionDomain3195300192024-03-31RelatedPartyTransactionDomain3195300192023-10-012024-03-31RelatedPartyTransactionDomain3205300192023-09-30RelatedPartyTransactionDomain3205300192024-03-31RelatedPartyTransactionDomain3205300192023-10-012024-03-31RelatedPartyTransactionDomain3215300192023-09-30RelatedPartyTransactionDomain3215300192024-03-31RelatedPartyTransactionDomain3215300192023-10-012024-03-31RelatedPartyTransactionDomain3225300192023-09-30RelatedPartyTransactionDomain3225300192024-03-31RelatedPartyTransactionDomain3225300192023-10-012024-03-31RelatedPartyTransactionDomain3235300192023-09-30RelatedPartyTransactionDomain3235300192024-03-31RelatedPartyTransactionDomain3235300192023-10-012024-03-31RelatedPartyTransactionDomain3245300192023-09-30RelatedPartyTransactionDomain3245300192024-03-31RelatedPartyTransactionDomain3245300192023-10-012024-03-31RelatedPartyTransactionDomain3255300192023-09-30RelatedPartyTransactionDomain3255300192024-03-31RelatedPartyTransactionDomain3255300192023-10-012024-03-31RelatedPartyTransactionDomain3265300192023-09-30RelatedPartyTransactionDomain3265300192024-03-31RelatedPartyTransactionDomain3265300192023-10-012024-03-31RelatedPartyTransactionDomain3275300192023-09-30RelatedPartyTransactionDomain3275300192024-03-31RelatedPartyTransactionDomain3275300192023-10-012024-03-31RelatedPartyTransactionDomain3285300192023-09-30RelatedPartyTransactionDomain3285300192024-03-31RelatedPartyTransactionDomain3285300192023-10-012024-03-31RelatedPartyTransactionDomain3295300192023-09-30RelatedPartyTransactionDomain3295300192024-03-31RelatedPartyTransactionDomain3295300192023-10-012024-03-31RelatedPartyTransactionDomain3305300192023-09-30RelatedPartyTransactionDomain3305300192024-03-31RelatedPartyTransactionDomain3305300192023-10-012024-03-31RelatedPartyTransactionDomain3315300192023-09-30RelatedPartyTransactionDomain3315300192024-03-31RelatedPartyTransactionDomain3315300192023-10-012024-03-31RelatedPartyTransactionDomain3325300192023-09-30RelatedPartyTransactionDomain3325300192024-03-31RelatedPartyTransactionDomain3325300192023-10-012024-03-31RelatedPartyTransactionDomain3335300192023-09-30RelatedPartyTransactionDomain3335300192024-03-31RelatedPartyTransactionDomain3335300192023-10-012024-03-31RelatedPartyTransactionDomain3345300192023-09-30RelatedPartyTransactionDomain3345300192024-03-31RelatedPartyTransactionDomain3345300192023-10-012024-03-31RelatedPartyTransactionDomain3355300192023-09-30RelatedPartyTransactionDomain3355300192024-03-31RelatedPartyTransactionDomain3355300192023-10-012024-03-31RelatedPartyTransactionDomain3365300192023-09-30RelatedPartyTransactionDomain3365300192024-03-31RelatedPartyTransactionDomain3365300192023-10-012024-03-31RelatedPartyTransactionDomain3375300192023-09-30RelatedPartyTransactionDomain3375300192024-03-31RelatedPartyTransactionDomain3375300192023-10-012024-03-31RelatedPartyTransactionDomain3385300192023-09-30RelatedPartyTransactionDomain3385300192024-03-31RelatedPartyTransactionDomain3385300192023-10-012024-03-31RelatedPartyTransactionDomain3395300192023-09-30RelatedPartyTransactionDomain3395300192024-03-31RelatedPartyTransactionDomain3395300192023-10-012024-03-31RelatedPartyTransactionDomain3405300192023-09-30RelatedPartyTransactionDomain3405300192024-03-31RelatedPartyTransactionDomain3405300192023-10-012024-03-31RelatedPartyTransactionDomain3415300192023-09-30RelatedPartyTransactionDomain3415300192024-03-31RelatedPartyTransactionDomain3415300192023-10-012024-03-31RelatedPartyTransactionDomain3425300192023-09-30RelatedPartyTransactionDomain3425300192024-03-31RelatedPartyTransactionDomain3425300192023-10-012024-03-31RelatedPartyTransactionDomain3435300192023-09-30RelatedPartyTransactionDomain3435300192024-03-31RelatedPartyTransactionDomain3435300192023-10-012024-03-31RelatedPartyTransactionDomain3445300192023-09-30RelatedPartyTransactionDomain3445300192024-03-31RelatedPartyTransactionDomain3445300192023-10-012024-03-31RelatedPartyTransactionDomain3455300192023-09-30RelatedPartyTransactionDomain3455300192024-03-31RelatedPartyTransactionDomain3455300192023-10-012024-03-31RelatedPartyTransactionDomain3465300192023-09-30RelatedPartyTransactionDomain3465300192024-03-31RelatedPartyTransactionDomain3465300192023-10-012024-03-31RelatedPartyTransactionDomain3475300192023-09-30RelatedPartyTransactionDomain3475300192024-03-31RelatedPartyTransactionDomain3475300192023-10-012024-03-31RelatedPartyTransactionDomain3485300192023-09-30RelatedPartyTransactionDomain3485300192024-03-31RelatedPartyTransactionDomain3485300192023-10-012024-03-31RelatedPartyTransactionDomain3495300192023-09-30RelatedPartyTransactionDomain3495300192024-03-31RelatedPartyTransactionDomain3495300192023-10-012024-03-31RelatedPartyTransactionDomain3505300192023-09-30RelatedPartyTransactionDomain3505300192024-03-31RelatedPartyTransactionDomain3505300192023-10-012024-03-31RelatedPartyTransactionDomain3515300192023-09-30RelatedPartyTransactionDomain3515300192024-03-31RelatedPartyTransactionDomain3515300192023-10-012024-03-31RelatedPartyTransactionDomain3525300192023-09-30RelatedPartyTransactionDomain3525300192024-03-31RelatedPartyTransactionDomain3525300192023-10-012024-03-31RelatedPartyTransactionDomain3535300192023-09-30RelatedPartyTransactionDomain3535300192024-03-31RelatedPartyTransactionDomain3535300192023-10-012024-03-31RelatedPartyTransactionDomain3545300192023-09-30RelatedPartyTransactionDomain3545300192024-03-31RelatedPartyTransactionDomain3545300192023-10-012024-03-31RelatedPartyTransactionDomain3555300192023-09-30RelatedPartyTransactionDomain3555300192024-03-31RelatedPartyTransactionDomain3555300192023-10-012024-03-31RelatedPartyTransactionDomain3565300192023-09-30RelatedPartyTransactionDomain3565300192024-03-31RelatedPartyTransactionDomain3565300192023-10-012024-03-31RelatedPartyTransactionDomain3575300192023-09-30RelatedPartyTransactionDomain3575300192024-03-31RelatedPartyTransactionDomain3575300192023-10-012024-03-31RelatedPartyTransactionDomain3585300192023-09-30RelatedPartyTransactionDomain3585300192024-03-31RelatedPartyTransactionDomain3585300192023-10-012024-03-31RelatedPartyTransactionDomain3595300192023-09-30RelatedPartyTransactionDomain3595300192024-03-31RelatedPartyTransactionDomain3595300192023-10-012024-03-31RelatedPartyTransactionDomain3605300192023-09-30RelatedPartyTransactionDomain3605300192024-03-31RelatedPartyTransactionDomain3605300192023-10-012024-03-31RelatedPartyTransactionDomain3615300192023-09-30RelatedPartyTransactionDomain3615300192024-03-31RelatedPartyTransactionDomain3615300192023-10-012024-03-31RelatedPartyTransactionDomain3625300192023-09-30RelatedPartyTransactionDomain3625300192024-03-31RelatedPartyTransactionDomain3625300192023-10-012024-03-31RelatedPartyTransactionDomain3635300192023-09-30RelatedPartyTransactionDomain3635300192024-03-31RelatedPartyTransactionDomain3635300192023-10-012024-03-31RelatedPartyTransactionDomain3645300192023-09-30RelatedPartyTransactionDomain3645300192024-03-31RelatedPartyTransactionDomain3645300192023-10-012024-03-31RelatedPartyTransactionDomain3655300192023-09-30RelatedPartyTransactionDomain3655300192024-03-31RelatedPartyTransactionDomain3655300192023-10-012024-03-31RelatedPartyTransactionDomain3665300192023-09-30RelatedPartyTransactionDomain3665300192024-03-31RelatedPartyTransactionDomain3665300192023-10-012024-03-31RelatedPartyTransactionDomain3675300192023-09-30RelatedPartyTransactionDomain3675300192024-03-31RelatedPartyTransactionDomain3675300192023-10-012024-03-31RelatedPartyTransactionDomain3685300192023-09-30RelatedPartyTransactionDomain3685300192024-03-31RelatedPartyTransactionDomain3685300192023-10-012024-03-31RelatedPartyTransactionDomain3695300192023-09-30RelatedPartyTransactionDomain3695300192024-03-31RelatedPartyTransactionDomain3695300192023-10-012024-03-31RelatedPartyTransactionDomain3705300192023-09-30RelatedPartyTransactionDomain3705300192024-03-31RelatedPartyTransactionDomain3705300192023-10-012024-03-31RelatedPartyTransactionDomain3715300192023-09-30RelatedPartyTransactionDomain3715300192024-03-31RelatedPartyTransactionDomain3715300192023-10-012024-03-31RelatedPartyTransactionDomain3725300192023-09-30RelatedPartyTransactionDomain3725300192024-03-31RelatedPartyTransactionDomain3725300192023-10-012024-03-31RelatedPartyTransactionDomain3735300192023-09-30RelatedPartyTransactionDomain3735300192024-03-31RelatedPartyTransactionDomain3735300192023-10-012024-03-31RelatedPartyTransactionDomain3745300192023-09-30RelatedPartyTransactionDomain3745300192024-03-31RelatedPartyTransactionDomain3745300192023-10-012024-03-31RelatedPartyTransactionDomain3755300192023-09-30RelatedPartyTransactionDomain3755300192024-03-31RelatedPartyTransactionDomain3755300192023-10-012024-03-31RelatedPartyTransactionDomain3765300192023-09-30RelatedPartyTransactionDomain3765300192024-03-31RelatedPartyTransactionDomain3765300192023-10-012024-03-31RelatedPartyTransactionDomain3775300192023-09-30RelatedPartyTransactionDomain3775300192024-03-31RelatedPartyTransactionDomain3775300192023-10-012024-03-31RelatedPartyTransactionDomain3785300192023-09-30RelatedPartyTransactionDomain3785300192024-03-31RelatedPartyTransactionDomain3785300192023-10-012024-03-31RelatedPartyTransactionDomain3795300192023-09-30RelatedPartyTransactionDomain3795300192024-03-31RelatedPartyTransactionDomain3795300192023-10-012024-03-31RelatedPartyTransactionDomain3805300192023-09-30RelatedPartyTransactionDomain3805300192024-03-31RelatedPartyTransactionDomain3805300192023-10-012024-03-31RelatedPartyTransactionDomain3815300192023-09-30RelatedPartyTransactionDomain3815300192024-03-31RelatedPartyTransactionDomain3815300192023-10-012024-03-31RelatedPartyTransactionDomain3825300192023-09-30RelatedPartyTransactionDomain3825300192024-03-31RelatedPartyTransactionDomain3825300192023-10-012024-03-31RelatedPartyTransactionDomain3835300192023-09-30RelatedPartyTransactionDomain3835300192024-03-31RelatedPartyTransactionDomain3835300192023-10-012024-03-31RelatedPartyTransactionDomain3845300192023-09-30RelatedPartyTransactionDomain3845300192024-03-31RelatedPartyTransactionDomain3845300192023-10-012024-03-31RelatedPartyTransactionDomain3855300192023-09-30RelatedPartyTransactionDomain3855300192024-03-31RelatedPartyTransactionDomain3855300192023-10-012024-03-31RelatedPartyTransactionDomain3865300192023-09-30RelatedPartyTransactionDomain3865300192024-03-31RelatedPartyTransactionDomain3865300192023-10-012024-03-31RelatedPartyTransactionDomain3875300192023-09-30RelatedPartyTransactionDomain3875300192024-03-31RelatedPartyTransactionDomain3875300192023-10-012024-03-31RelatedPartyTransactionDomain3885300192023-09-30RelatedPartyTransactionDomain3885300192024-03-31RelatedPartyTransactionDomain3885300192023-10-012024-03-31RelatedPartyTransactionDomain3895300192023-09-30RelatedPartyTransactionDomain3895300192024-03-31RelatedPartyTransactionDomain3895300192023-10-012024-03-31RelatedPartyTransactionDomain3905300192023-09-30RelatedPartyTransactionDomain3905300192024-03-31RelatedPartyTransactionDomain3905300192023-10-012024-03-31RelatedPartyTransactionDomain3915300192023-09-30RelatedPartyTransactionDomain3915300192024-03-31RelatedPartyTransactionDomain3915300192023-10-012024-03-31RelatedPartyTransactionDomain3925300192023-09-30RelatedPartyTransactionDomain3925300192024-03-31RelatedPartyTransactionDomain3925300192023-10-012024-03-31RelatedPartyTransactionDomain3935300192023-09-30RelatedPartyTransactionDomain3935300192024-03-31RelatedPartyTransactionDomain3935300192023-10-012024-03-31RelatedPartyTransactionDomain3945300192023-09-30RelatedPartyTransactionDomain3945300192024-03-31RelatedPartyTransactionDomain3945300192023-10-012024-03-31RelatedPartyTransactionDomain3955300192023-09-30RelatedPartyTransactionDomain3955300192024-03-31RelatedPartyTransactionDomain3955300192023-10-012024-03-31RelatedPartyTransactionDomain3965300192023-09-30RelatedPartyTransactionDomain3965300192024-03-31RelatedPartyTransactionDomain3965300192023-10-012024-03-31RelatedPartyTransactionDomain3975300192023-09-30RelatedPartyTransactionDomain3975300192024-03-31RelatedPartyTransactionDomain3975300192023-10-012024-03-31RelatedPartyTransactionDomain3985300192023-09-30RelatedPartyTransactionDomain3985300192024-03-31RelatedPartyTransactionDomain3985300192023-10-012024-03-31RelatedPartyTransactionDomain3995300192023-09-30RelatedPartyTransactionDomain3995300192024-03-31RelatedPartyTransactionDomain3995300192023-10-012024-03-31RelatedPartyTransactionDomain4005300192023-09-30RelatedPartyTransactionDomain4005300192024-03-31RelatedPartyTransactionDomain4005300192023-10-012024-03-31RelatedPartyTransactionDomain4015300192023-09-30RelatedPartyTransactionDomain4015300192024-03-31RelatedPartyTransactionDomain4015300192023-10-012024-03-31RelatedPartyTransactionDomain4025300192023-09-30RelatedPartyTransactionDomain4025300192024-03-31RelatedPartyTransactionDomain4025300192023-10-012024-03-31RelatedPartyTransactionDomain4035300192023-09-30RelatedPartyTransactionDomain4035300192024-03-31RelatedPartyTransactionDomain4035300192023-10-012024-03-31RelatedPartyTransactionDomain4045300192023-09-30RelatedPartyTransactionDomain4045300192024-03-31RelatedPartyTransactionDomain4045300192023-10-012024-03-31RelatedPartyTransactionDomain4055300192023-09-30RelatedPartyTransactionDomain4055300192024-03-31RelatedPartyTransactionDomain4055300192023-10-012024-03-31RelatedPartyTransactionDomain4065300192023-09-30RelatedPartyTransactionDomain4065300192024-03-31RelatedPartyTransactionDomain4065300192023-10-012024-03-31RelatedPartyTransactionDomain4075300192023-09-30RelatedPartyTransactionDomain4075300192024-03-31RelatedPartyTransactionDomain4075300192023-10-012024-03-31RelatedPartyTransactionDomain4085300192023-09-30RelatedPartyTransactionDomain4085300192024-03-31RelatedPartyTransactionDomain4085300192023-10-012024-03-31RelatedPartyTransactionDomain4095300192023-09-30RelatedPartyTransactionDomain4095300192024-03-31RelatedPartyTransactionDomain4095300192023-10-012024-03-31RelatedPartyTransactionDomain4105300192023-09-30RelatedPartyTransactionDomain4105300192024-03-31RelatedPartyTransactionDomain4105300192023-10-012024-03-31RelatedPartyTransactionDomain4115300192023-09-30RelatedPartyTransactionDomain4115300192024-03-31RelatedPartyTransactionDomain4115300192023-10-012024-03-31RelatedPartyTransactionDomain4125300192023-09-30RelatedPartyTransactionDomain4125300192024-03-31RelatedPartyTransactionDomain4125300192023-10-012024-03-31RelatedPartyTransactionDomain4135300192023-09-30RelatedPartyTransactionDomain4135300192024-03-31RelatedPartyTransactionDomain4135300192023-10-012024-03-31RelatedPartyTransactionDomain4145300192023-09-30RelatedPartyTransactionDomain4145300192024-03-31RelatedPartyTransactionDomain4145300192023-10-012024-03-31RelatedPartyTransactionDomain4155300192023-09-30RelatedPartyTransactionDomain4155300192024-03-31RelatedPartyTransactionDomain4155300192023-10-012024-03-31RelatedPartyTransactionDomain4165300192023-09-30RelatedPartyTransactionDomain4165300192024-03-31RelatedPartyTransactionDomain4165300192023-10-012024-03-31RelatedPartyTransactionDomain4175300192023-09-30RelatedPartyTransactionDomain4175300192024-03-31RelatedPartyTransactionDomain4175300192023-10-012024-03-31RelatedPartyTransactionDomain4185300192023-09-30RelatedPartyTransactionDomain4185300192024-03-31RelatedPartyTransactionDomain4185300192023-10-012024-03-31RelatedPartyTransactionDomain4195300192023-09-30RelatedPartyTransactionDomain4195300192024-03-31RelatedPartyTransactionDomain4195300192023-10-012024-03-31RelatedPartyTransactionDomain4205300192023-09-30RelatedPartyTransactionDomain4205300192024-03-31RelatedPartyTransactionDomain4205300192023-10-012024-03-31RelatedPartyTransactionDomain4215300192023-09-30RelatedPartyTransactionDomain4215300192024-03-31RelatedPartyTransactionDomain4215300192023-10-012024-03-31RelatedPartyTransactionDomain4225300192023-09-30RelatedPartyTransactionDomain4225300192024-03-31RelatedPartyTransactionDomain4225300192023-10-012024-03-31RelatedPartyTransactionDomain4235300192023-09-30RelatedPartyTransactionDomain4235300192024-03-31RelatedPartyTransactionDomain4235300192023-10-012024-03-31RelatedPartyTransactionDomain4245300192023-09-30RelatedPartyTransactionDomain4245300192024-03-31RelatedPartyTransactionDomain4245300192023-10-012024-03-31RelatedPartyTransactionDomain4255300192023-09-30RelatedPartyTransactionDomain4255300192024-03-31RelatedPartyTransactionDomain4255300192023-10-012024-03-31RelatedPartyTransactionDomain4265300192023-09-30RelatedPartyTransactionDomain4265300192024-03-31RelatedPartyTransactionDomain4265300192023-10-012024-03-31RelatedPartyTransactionDomain4275300192023-09-30RelatedPartyTransactionDomain4275300192024-03-31RelatedPartyTransactionDomain4275300192023-10-012024-03-31RelatedPartyTransactionDomain4285300192023-09-30RelatedPartyTransactionDomain4285300192024-03-31RelatedPartyTransactionDomain4285300192023-10-012024-03-31RelatedPartyTransactionDomain4295300192023-09-30RelatedPartyTransactionDomain4295300192024-03-31RelatedPartyTransactionDomain4295300192023-10-012024-03-31RelatedPartyTransactionDomain4305300192023-09-30RelatedPartyTransactionDomain4305300192024-03-31RelatedPartyTransactionDomain4305300192023-10-012024-03-31RelatedPartyTransactionDomain4315300192023-09-30RelatedPartyTransactionDomain4315300192024-03-31RelatedPartyTransactionDomain4315300192023-10-012024-03-31RelatedPartyTransactionDomain4325300192023-09-30RelatedPartyTransactionDomain4325300192024-03-31RelatedPartyTransactionDomain4325300192023-10-012024-03-31RelatedPartyTransactionDomain4335300192023-09-30RelatedPartyTransactionDomain4335300192024-03-31RelatedPartyTransactionDomain4335300192023-10-012024-03-31RelatedPartyTransactionDomain4345300192023-09-30RelatedPartyTransactionDomain4345300192024-03-31RelatedPartyTransactionDomain4345300192023-10-012024-03-31RelatedPartyTransactionDomain4355300192023-09-30RelatedPartyTransactionDomain4355300192024-03-31RelatedPartyTransactionDomain4355300192023-10-012024-03-31RelatedPartyTransactionDomain4365300192023-09-30RelatedPartyTransactionDomain4365300192024-03-31RelatedPartyTransactionDomain4365300192023-10-012024-03-31RelatedPartyTransactionDomain4375300192023-09-30RelatedPartyTransactionDomain4375300192024-03-31RelatedPartyTransactionDomain4375300192023-10-012024-03-31RelatedPartyTransactionDomain4385300192023-09-30RelatedPartyTransactionDomain4385300192024-03-31RelatedPartyTransactionDomain4385300192023-10-012024-03-31RelatedPartyTransactionDomain4395300192023-09-30RelatedPartyTransactionDomain4395300192024-03-31RelatedPartyTransactionDomain4395300192023-10-012024-03-31RelatedPartyTransactionDomain4405300192023-09-30RelatedPartyTransactionDomain4405300192024-03-31RelatedPartyTransactionDomain4405300192023-10-012024-03-31RelatedPartyTransactionDomain4415300192023-09-30RelatedPartyTransactionDomain4415300192024-03-31RelatedPartyTransactionDomain4415300192023-10-012024-03-31RelatedPartyTransactionDomain4425300192023-09-30RelatedPartyTransactionDomain4425300192024-03-31RelatedPartyTransactionDomain4425300192023-10-012024-03-31RelatedPartyTransactionDomain4435300192023-09-30RelatedPartyTransactionDomain4435300192024-03-31RelatedPartyTransactionDomain4435300192023-10-012024-03-31RelatedPartyTransactionDomain4445300192023-09-30RelatedPartyTransactionDomain4445300192024-03-31RelatedPartyTransactionDomain4445300192023-10-012024-03-31RelatedPartyTransactionDomain4455300192023-09-30RelatedPartyTransactionDomain4455300192024-03-31RelatedPartyTransactionDomain4455300192023-10-012024-03-31RelatedPartyTransactionDomain4465300192023-09-30RelatedPartyTransactionDomain4465300192024-03-31RelatedPartyTransactionDomain4465300192023-10-012024-03-31RelatedPartyTransactionDomain4475300192023-09-30RelatedPartyTransactionDomain4475300192024-03-31RelatedPartyTransactionDomain4475300192023-10-012024-03-31RelatedPartyTransactionDomain4485300192023-09-30RelatedPartyTransactionDomain4485300192024-03-31RelatedPartyTransactionDomain4485300192023-10-012024-03-31RelatedPartyTransactionDomain4495300192023-09-30RelatedPartyTransactionDomain4495300192024-03-31RelatedPartyTransactionDomain4495300192023-10-012024-03-31RelatedPartyTransactionDomain4505300192023-09-30RelatedPartyTransactionDomain4505300192024-03-31RelatedPartyTransactionDomain4505300192023-10-012024-03-31RelatedPartyTransactionDomain4515300192023-09-30RelatedPartyTransactionDomain4515300192024-03-31RelatedPartyTransactionDomain4515300192023-10-012024-03-31RelatedPartyTransactionDomain4525300192023-09-30RelatedPartyTransactionDomain4525300192024-03-31RelatedPartyTransactionDomain4525300192023-10-012024-03-31RelatedPartyTransactionDomain4535300192023-09-30RelatedPartyTransactionDomain4535300192024-03-31RelatedPartyTransactionDomain4535300192023-10-012024-03-31RelatedPartyTransactionDomain4545300192023-09-30RelatedPartyTransactionDomain4545300192024-03-31RelatedPartyTransactionDomain4545300192023-10-012024-03-31RelatedPartyTransactionDomain4555300192023-09-30RelatedPartyTransactionDomain4555300192024-03-31RelatedPartyTransactionDomain4555300192023-10-012024-03-31RelatedPartyTransactionDomain4565300192023-09-30RelatedPartyTransactionDomain4565300192024-03-31RelatedPartyTransactionDomain4565300192023-10-012024-03-31RelatedPartyTransactionDomain4575300192023-09-30RelatedPartyTransactionDomain4575300192024-03-31RelatedPartyTransactionDomain4575300192023-10-012024-03-31RelatedPartyTransactionDomain4585300192023-09-30RelatedPartyTransactionDomain4585300192024-03-31RelatedPartyTransactionDomain4585300192023-10-012024-03-31RelatedPartyTransactionDomain4595300192023-09-30RelatedPartyTransactionDomain4595300192024-03-31RelatedPartyTransactionDomain4595300192023-10-012024-03-31RelatedPartyTransactionDomain4605300192023-09-30RelatedPartyTransactionDomain4605300192024-03-31RelatedPartyTransactionDomain4605300192023-10-012024-03-31RelatedPartyTransactionDomain4615300192023-09-30RelatedPartyTransactionDomain4615300192024-03-31RelatedPartyTransactionDomain4615300192023-10-012024-03-31RelatedPartyTransactionDomain4625300192023-09-30RelatedPartyTransactionDomain4625300192024-03-31RelatedPartyTransactionDomain4625300192023-10-012024-03-31RelatedPartyTransactionDomain4635300192023-09-30RelatedPartyTransactionDomain4635300192024-03-31RelatedPartyTransactionDomain4635300192023-10-012024-03-31RelatedPartyTransactionDomain4645300192023-09-30RelatedPartyTransactionDomain4645300192024-03-31RelatedPartyTransactionDomain4645300192023-10-012024-03-31RelatedPartyTransactionDomain4655300192023-09-30RelatedPartyTransactionDomain4655300192024-03-31RelatedPartyTransactionDomain4655300192023-10-012024-03-31RelatedPartyTransactionDomain4665300192023-09-30RelatedPartyTransactionDomain4665300192024-03-31RelatedPartyTransactionDomain4665300192023-10-012024-03-31RelatedPartyTransactionDomain4675300192023-09-30RelatedPartyTransactionDomain4675300192024-03-31RelatedPartyTransactionDomain4675300192023-10-012024-03-31RelatedPartyTransactionDomain4685300192023-09-30RelatedPartyTransactionDomain4685300192024-03-31RelatedPartyTransactionDomain4685300192023-10-012024-03-31RelatedPartyTransactionDomain4695300192023-09-30RelatedPartyTransactionDomain4695300192024-03-31RelatedPartyTransactionDomain4695300192023-10-012024-03-31RelatedPartyTransactionDomain4705300192023-09-30RelatedPartyTransactionDomain4705300192024-03-31RelatedPartyTransactionDomain470iso4217:INRxbrli:pureJubilant Pharmova Limited530019JUBLPHARMANOTLISTED2023-04-012024-03-31Second half yearly2023-10-012024-03-31MillionstruetrueNANAfalseDrug Discovery and Development Solutions LimitedJubilant Therapeutics Inc.Fellow subsidiaryAny other transactionInterest ReceivableNone0444400000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></SPAN></DIV></DIV>Drug Discovery and Development Solutions LimitedJubilant Innovation (USA) Inc.SubsidiaryAny other transactionOther ReceivableNone03600000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>The transaction is between two wholly owned subsidiaries. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Biosys Innovative Research Services Pte LimitedDrug Discovery and Development Solutions LimitedFellow subsidiaryAny other transactionLoan ReceivableNone0249140000250220000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>The transaction is between two wholly owned subsidiaries. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Biosys Innovative Research Services Pte LimitedDrug Discovery and Development Solutions LimitedFellow subsidiaryAny other transactionInterest ReceivableNone0292000014850000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>The transaction is between two wholly owned subsidiaries. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Biosys LimitedJubilant Biosys Innovative Research Services Pte LimitedSubsidiaryAny other transactionLoan ReceivableNone0249140000250220000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>The transaction is between two wholly owned subsidiaries. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Biosys LimitedJubilant Biosys Innovative Research Services Pte LimitedSubsidiaryAny other transactionInterest ReceivableNone029800007950000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>The transaction is between two wholly owned subsidiaries. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Biosys LimitedJubilant Clinsys LimitedFellow subsidiaryAny other transactionOther ReceivableNone02000030000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>The transaction is between two wholly owned subsidiaries. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Biosys LimitedJubilant Discovery Services LLCFellow subsidiaryAny other transactionOther ReceivableNone00450000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>The transaction is between two wholly owned subsidiaries. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Biosys LimitedJubilant Discovery Services LLCFellow subsidiaryAny other transactionTrade payableNone06738000030550000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>The transaction is between two wholly owned subsidiaries. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Biosys LimitedJubilant Enpro Private LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone02700000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required</SPAN></DIV></DIV>Jubilant Biosys LimitedJubilant Epicore LLCFellow subsidiaryAny other transactionTrade ReceivableNone058500004160000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Biosys LimitedJubilant Epipad LLCFellow subsidiaryAny other transactionTrade ReceivableNone01730000025260000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Biosys LimitedJubilant Episcribe LLCFellow subsidiaryAny other transactionTrade ReceivableNone0104500008520000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Biosys LimitedJubilant FoodWorks LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone00520000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Biosys LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone074100005210000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Biosys LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade ReceivableNone080000170000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Biosys LimitedJubilant Prodel LLCFellow subsidiaryAny other transactionTrade ReceivableNone02630000260000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Biosys LimitedJubilant Therapeutics Inc.Fellow subsidiaryAny other transactionTrade ReceivableNone04520000028250000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Biosys LimitedJubilant Therapeutics India LimitedFellow subsidiaryAny other transactionOther ReceivableNone0350000860000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Biosys LimitedJubilant Therapeutics India LimitedFellow subsidiaryAny other transactionTrade ReceivableNone06900000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Cadista Pharmaceuticals Inc.Jubilant Business Services LimitedFellow subsidiaryAny other transactionTrade payableNone016600001660000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Cadista Pharmaceuticals Inc.Jubilant Discovery Services LLCFellow subsidiaryAny other transactionOther ReceivableNone0100000150000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Cadista Pharmaceuticals Inc.Jubilant Draximage (USA) Inc.Fellow subsidiaryAny other transactionOther ReceivableNone0380000490000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Cadista Pharmaceuticals Inc.Jubilant DraxImage Inc.Fellow subsidiaryAny other transactionOther ReceivableNone023300005560000<DIV > <DIV><SPAN style='FONT-SIZE: 15px; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FLOAT: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; DISPLAY: inline !important; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(232,234,216); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN></DIV></DIV>Jubilant Cadista Pharmaceuticals Inc.Jubilant HollisterStier General PartnershipFellow subsidiaryAny other transactionOther ReceivableNone002340000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Cadista Pharmaceuticals Inc.Jubilant HollisterStier LLCFellow subsidiaryAny other transactionOther ReceivableNone04642000057110000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Cadista Pharmaceuticals Inc.Jubilant Industries Inc. USAEnterprise in which Key management personnel are interestedAny other transactionOther ReceivableNone080000120000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Cadista Pharmaceuticals Inc.Jubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone062400001610000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Cadista Pharmaceuticals Inc.Jubilant Life Sciences (USA) Inc.Enterprise in which Key management personnel are interestedAny other transactionOther ReceivableNone0130000170000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Cadista Pharmaceuticals Inc.Jubilant Pharma Holdings Inc.Immediate parentAny other transactionOther ReceivableNone01324600000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Cadista Pharmaceuticals Inc.Jubilant Pharma ME FZ-LLCFellow subsidiaryAny other transactionLoan ReceivableNone03322000041700000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Cadista Pharmaceuticals Inc.Jubilant Pharma ME FZ-LLCFellow subsidiaryAny other transactionInterest ReceivableNone06900001480000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Cadista Pharmaceuticals Inc.Jubilant Therapeutics Inc.Fellow subsidiaryAny other transactionOther ReceivableNone0120000160000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Clinsys LimitedJubilant DraxImage LimitedFellow subsidiaryAny other transactionLoan ReceivableNone075000008000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Clinsys LimitedJubilant DraxImage LimitedFellow subsidiaryAny other transactionInterest ReceivableNone0460000240000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Clinsys LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone0010000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Discovery Services LLCDrug Discovery and Development Solutions LimitedIntermediate parentAny other transactionLoan ReceivableNone02491000025020000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Discovery Services LLCDrug Discovery and Development Solutions LimitedIntermediate parentAny other transactionInterest ReceivableNone06900001030000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Discovery Services LLCJubilant DraxImage Inc.Fellow subsidiaryAny other transactionTrade payableNone00230000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Discovery Services LLCJubilant Innovation (USA) Inc.Immediate parentAny other transactionOther ReceivableNone014400000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Discovery Services LLCJubilant Clinsys Inc.Fellow subsidiaryAny other transactionOther ReceivableNone0580000580000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Draximage (USA) Inc.Jubilant DraxImage Inc.Fellow subsidiaryAny other transactionOther ReceivableNone029300004570000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Draximage (USA) Inc.Jubilant DraxImage Inc.Fellow subsidiaryAny other transactionTrade ReceivableNone0135660000138890000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Draximage (USA) Inc.Jubilant Pharma Holdings Inc.Immediate parentAny other transactionTrade ReceivableNone0930000930000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant DraxImage Inc.Jubilant Business Services LimitedFellow subsidiaryAny other transactionOther ReceivableNone056800005710000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant DraxImage Inc.Jubilant Cadista Pharmaceuticals Inc.Fellow subsidiaryAny other transactionOther ReceivableNone056800006790000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant DraxImage Inc.Jubilant Draximage (USA) Inc.Fellow subsidiaryAny other transactionOther ReceivableNone0174000080000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant DraxImage Inc.Jubilant Draximage Radiopharmacies Inc.Fellow subsidiaryAny other transactionOther ReceivableNone06000060000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant DraxImage Inc.Jubilant Generics LimitedFellow subsidiaryAny other transactionOther ReceivableNone0280000360000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant DraxImage Inc.Jubilant HollisterStier General PartnershipFellow subsidiaryAny other transactionOther ReceivableNone02060000033410000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant DraxImage Inc.Jubilant HollisterStier General PartnershipFellow subsidiaryAny other transactionTrade ReceivableNone0073680000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant DraxImage Inc.Jubilant HollisterStier Inc.Fellow subsidiaryAny other transactionOther ReceivableNone090000400000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant DraxImage Inc.Jubilant HollisterStier LLCFellow subsidiaryAny other transactionOther ReceivableNone05297000021860000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant DraxImage Inc.Jubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone061200004830000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant DraxImage Inc.Jubilant Pharma LimitedImmediate parentAny other transactionLoan ReceivableNone01967959000021683210000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant DraxImage Inc.Jubilant Pharma LimitedImmediate parentAny other transactionInterest ReceivableNone049327000070000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant DraxImage Inc.Jubilant Therapeutics Inc.Fellow subsidiaryAny other transactionOther ReceivableNone022400003300000<DIV > <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <DIV></DIV></DIV>Jubilant DraxImage Inc.SOFIE Co.AssociatesAny other transactionTrade payableNone01312000010820000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant DraxImage Inc.SOFIE Co.AssociatesAny other transactionTrade ReceivableNone05000040000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant DraxImage Inc.TrialStat Solutions Inc.Fellow subsidiaryAny other transactionOther ReceivableNone01101000015930000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant DraxImage Inc.Draxis Pharma LLCFellow subsidiaryAny other transactionOther ReceivableNone00120000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant DraxImage LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone0010000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Draximage Radiopharmacies Inc.Jubilant DraxImage Inc.Fellow subsidiaryAny other transactionOther ReceivableNone0830000840000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Draximage Radiopharmacies Inc.Jubilant Pharma Holdings Inc.Immediate parentAny other transactionLoan ReceivableNone0373700000375320000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Draximage Radiopharmacies Inc.Jubilant Pharma Holdings Inc.Immediate parentAny other transactionInterest ReceivableNone05207000060380000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant Biosys LimitedFellow subsidiaryAny other transactionOther ReceivableNone0330000100000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant Biosys LimitedFellow subsidiaryAny other transactionTrade payableNone010900002300000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant Business Services LimitedFellow subsidiaryAny other transactionTrade payableNone0300000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant Cadista Pharmaceuticals Inc.Fellow subsidiaryAny other transactionAdvance from CustomersNone011773000028320000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant Cadista Pharmaceuticals Inc.Fellow subsidiaryAny other transactionOther ReceivableNone0283370000239850000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant Cadista Pharmaceuticals Inc.Fellow subsidiaryAny other transactionTrade payableNone0436170000236660000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant DraxImage Inc.Fellow subsidiaryAny other transactionOther ReceivableNone016560000380000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant DraxImage Inc.Fellow subsidiaryAny other transactionTrade payableNone05000050000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant FoodWorks LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone00410000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant HollisterStier General PartnershipFellow subsidiaryAny other transactionOther ReceivableNone01040000012790000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant HollisterStier LLCFellow subsidiaryAny other transactionOther ReceivableNone03880000013470000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant HollisterStier LLCFellow subsidiaryAny other transactionTrade payableNone014200002860000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionOther ReceivableNone091600000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone07780000078180000<DIV > <DIV></DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>Jubilant Generics LimitedJubilant Pharma Australia Pty LimitedFellow subsidiaryAny other transactionTrade payableNone0230000960000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant Pharma Holdings Inc.Fellow subsidiaryAny other transactionOther ReceivableNone011080000430000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant Pharma LimitedImmediate parentAny other transactionOther ReceivableNone070000250000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant Pharma LimitedImmediate parentAny other transactionTrade payableNone0112260000196150000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant Pharma ME FZ-LLCFellow subsidiaryAny other transactionTrade ReceivableNone01312000045710000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant Pharma SA (PTY) LimitedFellow subsidiaryAny other transactionTrade payableNone0300000<DIV > <DIV></DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>Jubilant Generics LimitedJubilant Pharma SA (PTY) LimitedFellow subsidiaryAny other transactionTrade ReceivableNone04381000083030000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant Pharma UK LimitedFellow subsidiaryAny other transactionTrade ReceivableNone0296250000602930000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant Pharmaceuticals NVStep down subsidiaryAny other transactionTrade payableNone087000012960000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedJubilant Therapeutics India LimitedFellow subsidiaryAny other transactionOther ReceivableNone00250000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Generics LimitedPSI Supply NVStep down subsidiaryAny other transactionTrade ReceivableNone013766000019400000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier General PartnershipJubilant Business Services LimitedFellow subsidiaryAny other transactionTrade ReceivableNone0990000980000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier General PartnershipJubilant Cadista Pharmaceuticals Inc.Fellow subsidiaryAny other transactionOther ReceivableNone038800003890000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier General PartnershipJubilant DraxImage Inc.Fellow subsidiaryAny other transactionOther ReceivableNone0145300008590000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier General PartnershipJubilant DraxImage Inc.Fellow subsidiaryAny other transactionTrade ReceivableNone043510000210000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier General PartnershipJubilant HollisterStier Inc.Immediate parentAny other transactionOther ReceivableNone068200006850000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier General PartnershipJubilant HollisterStier LLCFellow subsidiaryAny other transactionOther ReceivableNone01341000013080000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier General PartnershipJubilant HollisterStier LLCFellow subsidiaryAny other transactionTrade ReceivableNone021200002130000<DIV > <DIV></DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>Jubilant HollisterStier General PartnershipJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone023100004570000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier General PartnershipJubilant Pharma Holdings Inc.Intermediate parentAny other transactionOther ReceivableNone0390000390000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier General PartnershipJubilant Pharma Holdings Inc.Intermediate parentAny other transactionLoan ReceivableNone0830440000834030000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier General PartnershipJubilant Pharma Holdings Inc.Intermediate parentAny other transactionInterest ReceivableNone0187400003190000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier LLCJubilant Cadista Pharmaceuticals Inc.Fellow subsidiaryAny other transactionOther ReceivableNone0144100000145850000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier LLCJubilant Discovery Services LLCFellow subsidiaryAny other transactionOther ReceivableNone021700005730000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier LLCJubilant Draximage (USA) Inc.Fellow subsidiaryAny other transactionOther ReceivableNone03086000058570000<DIV > <DIV></DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>Jubilant HollisterStier LLCJubilant DraxImage Inc.Fellow subsidiaryAny other transactionOther ReceivableNone01136000015700000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier LLCJubilant DraxImage Inc.Fellow subsidiaryAny other transactionTrade payableNone0040700000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier LLCJubilant DraxImage Inc.Fellow subsidiaryAny other transactionTrade ReceivableNone0542000021860000<DIV > <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <DIV></DIV></DIV>Jubilant HollisterStier LLCJubilant HollisterStier General PartnershipFellow subsidiaryAny other transactionOther ReceivableNone0228000014090000<DIV > <DIV></DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>Jubilant HollisterStier LLCJubilant HollisterStier Inc.Fellow subsidiaryAny other transactionOther ReceivableNone056800005710000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier LLCJubilant Industries Inc. USAEnterprise in which Key management personnel are interestedAny other transactionOther ReceivableNone01030000010730000<DIV > <DIV></DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>Jubilant HollisterStier LLCJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone0130100007820000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier LLCJubilant Life Sciences (USA) Inc.Enterprise in which Key management personnel are interestedAny other transactionOther ReceivableNone01399000014940000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier LLCJubilant Pharma Holdings Inc.Immediate parentAny other transactionOther ReceivableNone0532800001143760000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier LLCJubilant Pharma Holdings Inc.Immediate parentAny other transactionTrade payableNone001803960000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier LLCJubilant Therapeutics Inc.Fellow subsidiaryAny other transactionOther ReceivableNone0954000015160000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier LLCJubilant Clinsys Inc.Fellow subsidiaryAny other transactionOther ReceivableNone023700002380000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant HollisterStier LLCDraxis Pharma LLCFellow subsidiaryAny other transactionOther ReceivableNone0120000130000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Innovation (USA) Inc.Drug Discovery and Development Solutions LimitedImmediate parentAny other transactionLoan ReceivableNone0107960000108430000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Innovation (USA) Inc.Drug Discovery and Development Solutions LimitedImmediate parentAny other transactionInterest ReceivableNone029800004440000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Innovation (USA) Inc.TrialStat Solutions Inc.Fellow subsidiaryAny other transactionLoan ReceivableNone0274000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Innovation (USA) Inc.TrialStat Solutions Inc.Fellow subsidiaryAny other transactionInterest ReceivableNone060900000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Drug Discovery and Development Solutions LimitedFellow subsidiaryAny other transactionLoan ReceivableNone021359200002395390000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Drug Discovery and Development Solutions LimitedFellow subsidiaryAny other transactionInterest ReceivableNone03622000067600000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant Biosys LimitedFellow subsidiaryAny other transactionOther ReceivableNone07250000850000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant Cadista Pharmaceuticals Inc.SubsidiaryAny other transactionOther ReceivableNone01180950000562940000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant Cadista Pharmaceuticals Inc.SubsidiaryAny other transactionTrade payableNone053134000033320000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant Cadista Pharmaceuticals Inc.SubsidiaryAny other transactionLoan ReceivableNone012582100001221960000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant Cadista Pharmaceuticals Inc.SubsidiaryAny other transactionInterest ReceivableNone03186000064160000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant Discovery Services LLCFellow subsidiaryAny other transactionOther ReceivableNone021200002560000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant Draximage (USA) Inc.SubsidiaryAny other transactionOther ReceivableNone04510000089140000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant DraxImage Inc.Fellow subsidiaryAny other transactionOther ReceivableNone02706000051590000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant DraxImage Inc.Fellow subsidiaryAny other transactionTrade payableNone04078000044590000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant Draximage Radiopharmacies Inc.SubsidiaryAny other transactionOther ReceivableNone01415000014410000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant Generics LimitedFellow subsidiaryAny other transactionOther ReceivableNone04766000033590000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant HollisterStier General PartnershipStep down subsidiaryAny other transactionOther ReceivableNone0303000017060000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant HollisterStier Inc.SubsidiaryAny other transactionOther ReceivableNone069700005740000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant HollisterStier LLCSubsidiaryAny other transactionOther ReceivableNone07008700000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant Industries Inc. USAEnterprise in which Key management personnel are interestedAny other transactionOther ReceivableNone0450000590000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone01800000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant Life Sciences (USA) Inc.Enterprise in which Key management personnel are interestedAny other transactionOther ReceivableNone03022000036330000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant Pharma LimitedImmediate parentAny other transactionLoan ReceivableNone02511281000025555290000<DIV > <DIV></DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>Jubilant Pharma Holdings Inc.Jubilant Pharma LimitedImmediate parentAny other transactionInterest ReceivableNone04086500000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant Therapeutics Inc.Fellow subsidiaryAny other transactionOther ReceivableNone028100003910000<DIV > <DIV></DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>Jubilant Pharma Holdings Inc.Jubilant Innovation (USA) Inc.Fellow subsidiaryAny other transactionOther ReceivableNone0820000830000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma Holdings Inc.Jubilant Clinsys Inc.SubsidiaryAny other transactionOther ReceivableNone05400001150000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma LimitedJubilant Cadista Pharmaceuticals Inc.Intermediate parentAny other transactionOther ReceivableNone0058610000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma LimitedJubilant DraxImage Inc.SubsidiaryAny other transactionOther ReceivableNone09135000034200000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma LimitedJubilant Pharma Australia Pty LimitedSubsidiaryAny other transactionOther ReceivableNone023500002080000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma LimitedJubilant Pharma Holdings Inc.SubsidiaryAny other transactionOther ReceivableNone045670000125940000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma LimitedMr. Shyam S. BhartiaKey management personnelAny other transactionBonus PayableNone010062000067910000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma LimitedSofie Biosciences Inc.AssociatesAny other transactionOther ReceivableNone00583840000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmaceuticals NVJubilant DraxImage Inc.Fellow subsidiaryAny other transactionTrade ReceivableNone0090000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmaceuticals NVJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionOther ReceivableNone01673000017050000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmaceuticals NVJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone05000050000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmaceuticals NVJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade ReceivableNone0140000140000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmaceuticals NVJubilant Life Sciences NVEnterprise in which Key management personnel are interestedAny other transactionOther ReceivableNone0680000550000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmaceuticals NVJubilant Pharma UK LimitedFellow subsidiaryAny other transactionOther ReceivableNone003260000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmaceuticals NVPSI Supply NVFellow subsidiaryAny other transactionOther ReceivableNone080000210000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmaceuticals NVJubilant Pharma NVImmediate parentAny other transactionOther ReceivableNone052900006250000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedDr. Ashok MisraKey management personnelAny other transactionCommission payableNone001640000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style="FONT-SIZE: 11.5pt; BACKGROUND: #e8ead8; COLOR: black; LINE-HEIGHT: 107%"><o:p><FONT face=Calibri>&nbsp;</FONT></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJOGPL Private LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade ReceivableNone02100000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Biosys LimitedSubsidiaryAny other transactionAdvance from CustomersNone0049750000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Biosys LimitedSubsidiaryAny other transactionTrade payableNone06270000072960000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Biosys LimitedSubsidiaryAny other transactionTrade ReceivableNone0194500000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Biosys LimitedSubsidiaryAny other transactionInterest PayableNone0303300000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Biosys LimitedSubsidiaryAny other transactionDeposits payableNone0010000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Biosys LimitedSubsidiaryInter-corporate depositNone0790000000790000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Cadista Pharmaceuticals Inc.Step down subsidiaryAny other transactionTrade payableNone01686000022400000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Cadista Pharmaceuticals Inc.Step down subsidiaryAny other transactionTrade ReceivableNone0267700000298270000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant DraxImage Inc.Step down subsidiaryAny other transactionOther ReceivableNone0560000570000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant DraxImage Inc.Step down subsidiaryAny other transactionTrade payableNone02000060000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant DraxImage Inc.Step down subsidiaryAny other transactionTrade ReceivableNone013873000024010000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Employee Welfare TrustSubsidiaryAny other transactionTrade ReceivableNone0145300002570000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Employee Welfare TrustSubsidiaryAny other transactionInterest PayableNone03990000010020000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Employee Welfare TrustSubsidiaryInter-corporate depositNone0710000000700000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Enpro Private LimitedEnterprise in which Key management personnel are interestedAny other transactionDeposits recoverableNone0420000420000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Enpro Private LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade ReceivableNone0132200007380000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant First Trust Healthcare LimitedSubsidiaryAny other transactionTrade ReceivableNone0100000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant FoodWorks LimitedEnterprise in which Key management personnel are interestedAny other transactionAdvance from CustomersNone0023790000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant FoodWorks LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone00690000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant FoodWorks LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade ReceivableNone071900000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Generics LimitedStep down subsidiaryAny other transactionOther ReceivableNone0031660000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Generics LimitedStep down subsidiaryAny other transactionTrade payableNone016100000<DIV > <DIV></DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>Jubilant Pharmova LimitedJubilant Generics LimitedStep down subsidiaryAny other transactionTrade ReceivableNone0363000000262010000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant HollisterStier General PartnershipStep down subsidiaryAny other transactionTrade ReceivableNone01808000030250000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant HollisterStier LLCStep down subsidiaryAny other transactionTrade payableNone018300003720000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant HollisterStier LLCStep down subsidiaryAny other transactionTrade ReceivableNone0075340000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionAdvance to suppliersNone012200000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionOther ReceivableNone0101400000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone0276800004220000<DIV > <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <DIV></DIV></DIV>Jubilant Pharmova LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade ReceivableNone02100000048000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionDeposits payableNone005000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Life Sciences (Shanghai) LtdEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone01220000018990000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Pharma Holdings Inc.Step down subsidiaryAny other transactionAdvance from CustomersNone0096340000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Pharma Holdings Inc.Step down subsidiaryAny other transactionTrade payableNone0101230000118160000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Pharma Holdings Inc.Step down subsidiaryAny other transactionTrade ReceivableNone0458700000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Pharma ME FZ-LLCStep down subsidiaryAny other transactionTrade ReceivableNone0760000770000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. Arun SethKey management personnelAny other transactionCommission payableNone001640000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. Hari S. BhartiaKey management personnelAny other transactionCommission payableNone00870000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. S SridharKey management personnelAny other transactionCommission payableNone001640000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. Shirish G. BelapureKey management personnelAny other transactionCommission payableNone001640000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. Sushil Kumar RoongtaKey management personnelAny other transactionCommission payableNone001680000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. Vivek MehraKey management personnelAny other transactionCommission payableNone001680000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMs. Sudha PillaiKey management personnelAny other transactionCommission payableNone001640000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Consumer Private LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade ReceivableNone0800000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Agri and Consumer Products LimitedEnterprise in which Key management personnel are interestedAny other transactionOther ReceivableNone019900001990000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Agri and Consumer Products LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade ReceivableNone0120300002650000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Therapeutics Inc.Jubilant Epicore LLCSubsidiaryAny other transactionOther ReceivableNone01311000030590000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Therapeutics Inc.Jubilant Epipad LLCSubsidiaryAny other transactionOther ReceivableNone01055000023970000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Therapeutics Inc.Jubilant Episcribe LLCSubsidiaryAny other transactionOther ReceivableNone01223000027140000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Therapeutics Inc.Jubilant Prodel LLCSubsidiaryAny other transactionOther ReceivableNone050300006440000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Therapeutics Inc.Jubilant Innovation (USA) Inc.Fellow subsidiaryAny other transactionOther ReceivableNone09700000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Therapeutics India LimitedJubilant Enpro Private LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone0100000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Therapeutics India LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone09000070000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Therapeutics India LimitedJubilant Therapeutics Inc.SubsidiaryAny other transactionOther ReceivableNone01900000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Therapeutics India LimitedJubilant Therapeutics Inc.SubsidiaryAny other transactionTrade ReceivableNone06402000048710000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Therapeutics India LimitedJubilant Therapeutics Inc.SubsidiaryAny other transactionInterest ReceivableNone0133600006070000<DIV > <DIV></DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>PSI Supply NVJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionOther ReceivableNone001340000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>PSI Supply NVJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone088100008990000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>PSI Supply NVJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade ReceivableNone013100000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>PSI Supply NVJubilant Life Sciences NVEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone0060000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>PSI Supply NVJubilant Pharma UK LimitedFellow subsidiaryAny other transactionOther ReceivableNone0020270000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>PSI Supply NVJubilant Pharma UK LimitedFellow subsidiaryAny other transactionTrade ReceivableNone085600000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>PSI Supply NVJubilant Pharmaceuticals NVFellow subsidiaryAny other transactionOther ReceivableNone07417000097070000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>PSI Supply NVJubilant Pharmaceuticals NVFellow subsidiaryAny other transactionTrade ReceivableNone088700000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>PSI Supply NVJubilant Pharma NVImmediate parentAny other transactionOther ReceivableNone00180000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>TrialStat Solutions Inc.Jubilant DraxImage Inc.Fellow subsidiaryAny other transactionTrade ReceivableNone0760000750000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>TrialStat Solutions Inc.Jubilant Epicore LLCFellow subsidiaryAny other transactionTrade ReceivableNone01212000012330000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>TrialStat Solutions Inc.Jubilant Life Sciences (USA) Inc.Enterprise in which Key management personnel are interestedAny other transactionOther ReceivableNone002610000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Draxis Pharma LLCJubilant HollisterStier Inc.Immediate parentAny other transactionLoan ReceivableNone02051000020600000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Business Services LimitedJubilant HollisterStier LLCFellow subsidiaryAny other transactionTrade ReceivableNone0440000440000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Business Services LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone0010000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant First Trust Healthcare LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone01000010000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Employees Welfare TrustJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionTrade payableNone01000010000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>There is closing balance, however, no transaction during the half year end. Therefore, no Audit Committee approval is required.</SPAN><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Drug Discovery and Development Solutions LimitedJubilant Therapeutics Inc.Fellow subsidiaryInvestment1210000000None24930000000Loan0.04284 YearsInvestment0.04415 YearsUnsecuredBusiness PurposeDrug Discovery and Development Solutions LimitedJubilant Therapeutics Inc.Fellow subsidiaryInterest received150000000None5251000000Jubilant Biosys Innovative Research Services Pte LimitedDrug Discovery and Development Solutions LimitedFellow subsidiaryInterest received0None1188000000Jubilant Biosys LimitedJubilant Bhartia FoundationOther related partyAny other transactionDonation22540000None1127000000Jubilant Biosys LimitedJubilant Biosys Innovative Research Services Pte LimitedSubsidiaryInterest received20000000None1163000000Jubilant Biosys LimitedJubilant Clinsys LimitedFellow subsidiaryAny other transactionRecovery of Expenses1000000None1000000Jubilant Biosys LimitedJubilant Discovery Services LLCFellow subsidiaryAny other transactionRecovery of Expenses10000000None91000000Jubilant Biosys LimitedJubilant Discovery Services LLCFellow subsidiaryAny other transactionReimbursement of expenses150000000None2675000000Jubilant Biosys LimitedJubilant DraxImage Inc.Fellow subsidiarySale of goods or services5000000None453000000Jubilant Biosys LimitedJubilant Enpro Private LimitedEnterprise in which Key management personnel are interestedAny other transactionReimbursement of expenses1500000None-27000000Jubilant Biosys LimitedJubilant Epicore LLCFellow subsidiarySale of goods or services50000000None223000000Jubilant Biosys LimitedJubilant Epipad LLCFellow subsidiarySale of goods or services50000000None2119000000Jubilant Biosys LimitedJubilant Episcribe LLCFellow subsidiarySale of goods or services50000000None522000000Jubilant Biosys LimitedJubilant FoodWorks LimitedEnterprise in which Key management personnel are interestedAny other transactionReimbursement of expenses520000None52000000Jubilant Biosys LimitedJubilant Generics LimitedFellow subsidiarySale of goods or services50000000None150000000Jubilant Biosys LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionLease Payments0None1000000Jubilant Biosys LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionRecovery of Expenses0None3000000Jubilant Biosys LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionReimbursement of expenses0None3931000000Jubilant Biosys LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedPurchase of goods or services0None5000000Jubilant Biosys LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedSale of goods or services0None17000000Jubilant Biosys LimitedJubilant Pharma Holdings Inc.Fellow subsidiaryPurchase of goods or services16000000None510000000Jubilant Biosys LimitedJubilant Therapeutics Inc.Fellow subsidiarySale of goods or services150000000None1855000000Jubilant Biosys LimitedJubilant Therapeutics India LimitedFellow subsidiaryAny other transactionRental and other income5000000None114000000Jubilant Cadista Pharmaceuticals Inc.Jubilant Discovery Services LLCFellow subsidiaryAny other transactionRecovery of Expenses0None4000000Jubilant Cadista Pharmaceuticals Inc.Jubilant Draximage (USA) Inc.Fellow subsidiaryAny other transactionRecovery of Expenses0None11000000Jubilant Cadista Pharmaceuticals Inc.Jubilant DraxImage Inc.Fellow subsidiaryAny other transactionRecovery of Expenses0None304000000Jubilant Cadista Pharmaceuticals Inc.Jubilant HollisterStier General PartnershipFellow subsidiaryAny other transactionRecovery of Expenses0None234000000Jubilant Cadista Pharmaceuticals Inc.Jubilant HollisterStier LLCFellow subsidiaryAny other transactionRecovery of Expenses0None1047000000Jubilant Cadista Pharmaceuticals Inc.Jubilant Industries Inc. USAEnterprise in which Key management personnel are interestedAny other transactionRecovery of Expenses0None4000000Jubilant Cadista Pharmaceuticals Inc.Jubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionReimbursement of expenses0None482000000Jubilant Cadista Pharmaceuticals Inc.Jubilant Life Sciences (USA) Inc.Enterprise in which Key management personnel are interestedAny other transactionRecovery of Expenses0None4000000Jubilant Cadista Pharmaceuticals Inc.Jubilant Pharma ME FZ-LLCFellow subsidiaryAny other transactionLoans given0None831000000Loan0.04992 YearsUnsecuredBusiness PurposeJubilant Cadista Pharmaceuticals Inc.Jubilant Pharma ME FZ-LLCFellow subsidiaryInterest received0None79000000Jubilant Cadista Pharmaceuticals Inc.Jubilant Therapeutics Inc.Fellow subsidiaryAny other transactionRecovery of Expenses10000000None4000000Jubilant Clinsys LimitedJubilant DraxImage LimitedFellow subsidiaryInterest received0None31000000Jubilant Clinsys LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionLease Payments20000None1000000Jubilant Discovery Services LLCDrug Discovery and Development Solutions LimitedIntermediate parentInterest received0None45000000Jubilant Discovery Services LLCJubilant DraxImage Inc.Fellow subsidiaryAny other transactionReimbursement of expenses0None23000000Jubilant Draximage (USA) Inc.Jubilant DraxImage Inc.Fellow subsidiaryAny other transactionRecovery of Expenses0None359000000Jubilant Draximage (USA) Inc.Jubilant DraxImage Inc.Fellow subsidiarySale of goods or services0None43801000000Jubilant DraxImage Inc.Jubilant Cadista Pharmaceuticals Inc.Fellow subsidiaryAny other transactionRecovery of Expenses0None184000000Jubilant DraxImage Inc.Jubilant Cadista Pharmaceuticals Inc.Fellow subsidiaryAny other transactionReimbursement of expenses0None260000000Jubilant DraxImage Inc.Jubilant Draximage (USA) Inc.Fellow subsidiaryAny other transactionRecovery of Expenses0None35000000Jubilant DraxImage Inc.Jubilant HollisterStier General PartnershipFellow subsidiaryAny other transactionRecovery of Expenses0None1305000000Jubilant DraxImage Inc.Jubilant HollisterStier Inc.Fellow subsidiaryAny other transactionRecovery of Expenses0None31000000Jubilant DraxImage Inc.Jubilant HollisterStier LLCFellow subsidiaryAny other transactionRecovery of Expenses0None1188000000Jubilant DraxImage Inc.Jubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionReimbursement of expenses0None964000000Jubilant DraxImage Inc.Jubilant Pharma Holdings Inc.Fellow subsidiaryAny other transactionRecovery of Expenses0None714000000Jubilant DraxImage Inc.Jubilant Pharma LimitedImmediate parentAny other transactionLoans given0None190979000000Loan0.067 YearsUnsecuredBusiness PurposeJubilant DraxImage Inc.Jubilant Pharma LimitedImmediate parentInterest received0None54480000000Jubilant DraxImage Inc.Jubilant Therapeutics Inc.Fellow subsidiaryAny other transactionRecovery of Expenses10000000None104000000Jubilant DraxImage Inc.SOFIE Co.AssociatesPurchase of goods or services0None1302000000Jubilant DraxImage Inc.SOFIE Co.AssociatesSale of goods or services0None16000000Jubilant DraxImage Inc.TrialStat Solutions Inc.Fellow subsidiaryAny other transactionRecovery of Expenses0None489000000Jubilant DraxImage Inc.Draxis Pharma LLCFellow subsidiaryAny other transactionRecovery of Expenses0None12000000Jubilant DraxImage LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionLease Payments20000None1000000Jubilant Draximage Radiopharmacies Inc.Jubilant Pharma Holdings Inc.Immediate parentInterest received0None807000000Jubilant Generics LimitedJubilant Biosys LimitedFellow subsidiarySale of goods or services20000000None156000000Jubilant Generics LimitedJubilant Cadista Pharmaceuticals Inc.Fellow subsidiaryAny other transactionRecovery of Expenses10000000None176000000Jubilant Generics LimitedJubilant Cadista Pharmaceuticals Inc.Fellow subsidiaryAny other transactionReimbursement of expenses20000000None426000000Jubilant Generics LimitedJubilant Cadista Pharmaceuticals Inc.Fellow subsidiarySale of goods or services790000000None24448000000Jubilant Generics LimitedJubilant DraxImage Inc.Fellow subsidiaryAny other transactionRecovery of Expenses5000000None81000000Jubilant Generics LimitedJubilant DraxImage Inc.Fellow subsidiaryAny other transactionReimbursement of expenses0None8000000Jubilant Generics LimitedJubilant DraxImage Inc.Fellow subsidiarySale of goods or services85000000None619000000Jubilant Generics LimitedJubilant FoodWorks LimitedEnterprise in which Key management personnel are interestedAny other transactionReimbursement of expenses10000000None45000000Jubilant Generics LimitedJubilant HollisterStier General PartnershipFellow subsidiarySale of goods or services50000000None250000000Jubilant Generics LimitedJubilant HollisterStier LLCFellow subsidiaryAny other transactionReimbursement of expenses5000000None144000000Jubilant Generics LimitedJubilant HollisterStier LLCFellow subsidiarySale of goods or services80000000None1199000000Jubilant Generics LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionRecovery of Expenses15000000None1000000Jubilant Generics LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionReimbursement of expenses10000000None3000000Jubilant Generics LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionReimbursement of expenses60000000None2562000000Jubilant Generics LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedSale of fixed assets5000000None41000000Jubilant Generics LimitedJubilant Pharma Australia Pty LimitedFellow subsidiaryPurchase of goods or services10000000None120000000Jubilant Generics LimitedJubilant Pharma Holdings Inc.Fellow subsidiaryAny other transactionReimbursement of expenses10000000None100000000Jubilant Generics LimitedJubilant Pharma Holdings Inc.Fellow subsidiaryPurchase of goods or services50000000None906000000Jubilant Generics LimitedJubilant Pharma Holdings Inc.Fellow subsidiarySale of goods or services170000000None42000000Jubilant Generics LimitedJubilant Pharma LimitedImmediate parentAny other transactionRecovery of Expenses10000000None22000000Jubilant Generics LimitedJubilant Pharma LimitedImmediate parentAny other transactionReimbursement of expenses100000000None8335000000Jubilant Generics LimitedJubilant Pharma ME FZ-LLCFellow subsidiaryAny other transactionOther income12780000None415000000Jubilant Generics LimitedJubilant Pharma ME FZ-LLCFellow subsidiarySale of goods or services87220000None2832000000Jubilant Generics LimitedJubilant Pharma SA (PTY) LimitedFellow subsidiarySale of goods or services200000000None6940000000Jubilant Generics LimitedJubilant Pharma UK LimitedFellow subsidiarySale of goods or services1000000000None58454000000Jubilant Generics LimitedJubilant Pharmaceuticals NVStep down subsidiaryAny other transactionReimbursement of expenses100000000None4555000000Jubilant Generics LimitedJubilant Therapeutics India LimitedFellow subsidiarySale of goods or services10000000None28000000Jubilant Generics LimitedPSI Supply NVStep down subsidiaryAny other transactionReimbursement of expenses0None32000000Jubilant Generics LimitedPSI Supply NVStep down subsidiarySale of goods or services200000000None2725000000Jubilant HollisterStier General PartnershipJubilant DraxImage Inc.Fellow subsidiaryAny other transactionRecovery of Expenses0None8615000000Jubilant HollisterStier General PartnershipJubilant DraxImage Inc.Fellow subsidiarySale of goods or services0None23051000000Jubilant HollisterStier General PartnershipJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionReimbursement of expenses0None229000000Jubilant HollisterStier General PartnershipJubilant Pharma Holdings Inc.Intermediate parentInterest received0None1877000000Jubilant HollisterStier LLCJubilant Cadista Pharmaceuticals Inc.Fellow subsidiaryAny other transactionRecovery of Expenses0None112000000Jubilant HollisterStier LLCJubilant Discovery Services LLCFellow subsidiaryAny other transactionRecovery of Expenses0None354000000Jubilant HollisterStier LLCJubilant Draximage (USA) Inc.Fellow subsidiaryAny other transactionRecovery of Expenses0None2747000000Jubilant HollisterStier LLCJubilant DraxImage Inc.Fellow subsidiaryAny other transactionRecovery of Expenses0None666000000Jubilant HollisterStier LLCJubilant DraxImage Inc.Fellow subsidiarySale of goods or services0None8943000000Jubilant HollisterStier LLCJubilant HollisterStier General PartnershipFellow subsidiaryAny other transactionRecovery of Expenses0None1177000000Jubilant HollisterStier LLCJubilant Industries Inc. USAEnterprise in which Key management personnel are interestedAny other transactionRecovery of Expenses0None38000000Jubilant HollisterStier LLCJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionReimbursement of expenses0None778000000Jubilant HollisterStier LLCJubilant Life Sciences (USA) Inc.Enterprise in which Key management personnel are interestedAny other transactionRecovery of Expenses0None88000000Jubilant HollisterStier LLCJubilant Pharma Holdings Inc.Immediate parentAny other transactionRecovery of Expenses0None597000000Jubilant HollisterStier LLCJubilant Therapeutics Inc.Fellow subsidiaryAny other transactionRecovery of Expenses20000000None555000000Jubilant Innovation (USA) Inc.Drug Discovery and Development Solutions LimitedImmediate parentInterest received0None193000000Jubilant Innovation (USA) Inc.TrialStat Solutions Inc.Fellow subsidiaryInterest received0None49000000Jubilant Pharma Holdings Inc.Drug Discovery and Development Solutions LimitedFellow subsidiaryAny other transactionLoans given0None24930000000Loan0.04284 YearsUnsecuredBusiness PurposeJubilant Pharma Holdings Inc.Drug Discovery and Development Solutions LimitedFellow subsidiaryInterest received0None4300000000Jubilant Pharma Holdings Inc.Jubilant Cadista Pharmaceuticals Inc.SubsidiaryAny other transactionLoans given0None45708000000Loan0.03975 YearsUnsecuredBusiness PurposeJubilant Pharma Holdings Inc.Jubilant Cadista Pharmaceuticals Inc.SubsidiaryAny other transactionLoans received back0None49820000000Jubilant Pharma Holdings Inc.Jubilant Cadista Pharmaceuticals Inc.SubsidiaryAny other transactionRecovery of Expenses0None6504000000Jubilant Pharma Holdings Inc.Jubilant Cadista Pharmaceuticals Inc.SubsidiaryAny other transactionReimbursement of expenses0None73232000000Jubilant Pharma Holdings Inc.Jubilant Cadista Pharmaceuticals Inc.SubsidiaryInterest received0None3205000000Jubilant Pharma Holdings Inc.Jubilant Cadista Pharmaceuticals Inc.SubsidiarySale of goods or services0None4714000000Jubilant Pharma Holdings Inc.Jubilant Discovery Services LLCFellow subsidiaryAny other transactionRecovery of Expenses0None42000000Jubilant Pharma Holdings Inc.Jubilant Draximage (USA) Inc.SubsidiaryAny other transactionRecovery of Expenses0None4367000000Jubilant Pharma Holdings Inc.Jubilant DraxImage Inc.Fellow subsidiaryAny other transactionRecovery of Expenses0None22584000000Jubilant Pharma Holdings Inc.Jubilant DraxImage Inc.Fellow subsidiarySale of goods or services0None16995000000Jubilant Pharma Holdings Inc.Jubilant Draximage Radiopharmacies Inc.SubsidiaryAny other transactionRecovery of Expenses0None19000000Jubilant Pharma Holdings Inc.Jubilant HollisterStier General PartnershipStep down subsidiaryAny other transactionRecovery of Expenses0None585000000Jubilant Pharma Holdings Inc.Jubilant HollisterStier General PartnershipStep down subsidiarySale of goods or services0None813000000Jubilant Pharma Holdings Inc.Jubilant HollisterStier Inc.SubsidiaryAny other transactionReimbursement of expenses0None125000000Jubilant Pharma Holdings Inc.Jubilant HollisterStier LLCSubsidiaryAny other transactionRecovery of Expenses0None151776000000Jubilant Pharma Holdings Inc.Jubilant HollisterStier LLCSubsidiarySale of goods or services0None17970000000Jubilant Pharma Holdings Inc.Jubilant HollisterStier LLCSubsidiaryDividend received0None124844000000Jubilant Pharma Holdings Inc.Jubilant Industries Inc. USAEnterprise in which Key management personnel are interestedAny other transactionRecovery of Expenses0None10000000Jubilant Pharma Holdings Inc.Jubilant Life Sciences (USA) Inc.Enterprise in which Key management personnel are interestedAny other transactionRecovery of Expenses0None72000000Jubilant Pharma Holdings Inc.Jubilant Life Sciences (USA) Inc.Enterprise in which Key management personnel are interestedAny other transactionReimbursement of expenses0None29000000Jubilant Pharma Holdings Inc.Jubilant Life Sciences (USA) Inc.Enterprise in which Key management personnel are interestedSale of goods or services0None545000000Jubilant Pharma Holdings Inc.Jubilant Pharma LimitedImmediate parentAny other transactionLoans given0None33214000000Loan0.04138 YearsUnsecuredBusiness PurposeJubilant Pharma Holdings Inc.Jubilant Pharma LimitedImmediate parentInterest received0None40954000000Jubilant Pharma Holdings Inc.Jubilant Therapeutics Inc.Fellow subsidiaryAny other transactionRecovery of Expenses10000000None109000000Jubilant Pharma Holdings Inc.Jubilant Clinsys Inc.SubsidiaryAny other transactionRecovery of Expenses0None61000000Jubilant Pharma LimitedJubilant Cadista Pharmaceuticals Inc.Intermediate parentAny other transactionRecovery of Expenses0None5848000000Jubilant Pharma LimitedJubilant DraxImage Inc.SubsidiaryAny other transactionRecovery of Expenses0None224000000Jubilant Pharma LimitedJubilant DraxImage Inc.SubsidiarySale of goods or services0None7982000000Jubilant Pharma LimitedJubilant Pharma Holdings Inc.SubsidiarySale of goods or services0None7982000000Jubilant Pharma LimitedMr. Shyam S. BhartiaKey management personnelRemuneration0None10877000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharma LimitedSofie Biosciences Inc.AssociatesAny other transactionOther income0None58124000000Jubilant Pharma LimitedSofie Network, Inc.AssociatesDividend received300000000None26896000000Jubilant Pharmaceuticals NVJubilant DraxImage Inc.Fellow subsidiaryAny other transactionRecovery of Expenses0None9000000Jubilant Pharmaceuticals NVJubilant Life Sciences NVEnterprise in which Key management personnel are interestedAny other transactionRecovery of Expenses5000000None124000000Jubilant Pharmaceuticals NVJubilant Pharma UK LimitedFellow subsidiaryAny other transactionRecovery of Expenses0None433000000Jubilant Pharmaceuticals NVPSI Supply NVFellow subsidiaryAny other transactionRecovery of Expenses0None79000000Jubilant Pharmova LimitedDr. Ashok MisraKey management personnelAny other transactionCommission0None150000000Jubilant Pharmova LimitedDr. Ashok MisraKey management personnelAny other transactionSitting fees and director fees0None43000000Jubilant Pharmova LimitedJOGPL Private LimitedEnterprise in which Key management personnel are interestedAny other transactionRental and other income20000000None48000000Jubilant Pharmova LimitedJubilant Bhartia FoundationOther related partyAny other transactionDonation50000000None1450000000Jubilant Pharmova LimitedJubilant Biosys LimitedSubsidiaryAny other transactionReimbursement of expenses170000000None4979000000Jubilant Pharmova LimitedJubilant Biosys LimitedSubsidiaryAny other transactionRental and other income610000000None18606000000Jubilant Pharmova LimitedJubilant Biosys LimitedSubsidiaryInterest paid80000000None3668000000Jubilant Pharmova LimitedJubilant Biosys LimitedSubsidiarySale of goods or services140000000None3033000000Jubilant Pharmova LimitedJubilant Cadista Pharmaceuticals Inc.Step down subsidiaryAny other transactionReimbursement of expenses20000000None544000000Jubilant Pharmova LimitedJubilant Cadista Pharmaceuticals Inc.Step down subsidiaryAny other transactionRental and other income40000000None1148000000Jubilant Pharmova LimitedJubilant Cadista Pharmaceuticals Inc.Step down subsidiarySale of goods or services590000000None10703000000Jubilant Pharmova LimitedJubilant DraxImage Inc.Step down subsidiaryAny other transactionReimbursement of expenses10000000None4000000Jubilant Pharmova LimitedJubilant DraxImage Inc.Step down subsidiaryAny other transactionRental and other income100000000None4140000000Jubilant Pharmova LimitedJubilant DraxImage Inc.Step down subsidiarySale of goods or services380000000None18479000000Jubilant Pharmova LimitedJubilant Employee Welfare TrustSubsidiaryAny other transactionRecovery of Expenses30000000None523000000Jubilant Pharmova LimitedJubilant Employee Welfare TrustSubsidiaryAny other transactionRedemption of non convertible debendtures250000000None1000000000Jubilant Pharmova LimitedJubilant Employee Welfare TrustSubsidiaryInterest paid80000000None2589000000Jubilant Pharmova LimitedJubilant Enpro Private LimitedEnterprise in which Key management personnel are interestedAny other transactionReimbursement of expenses20000000None23000000Jubilant Pharmova LimitedJubilant Enpro Private LimitedEnterprise in which Key management personnel are interestedAny other transactionRental and other income60000000None1617000000Jubilant Pharmova LimitedJubilant FoodWorks LimitedEnterprise in which Key management personnel are interestedAny other transactionRecovery of Expenses20000000None41000000Jubilant Pharmova LimitedJubilant FoodWorks LimitedEnterprise in which Key management personnel are interestedAny other transactionReimbursement of expenses40000000None75000000Jubilant Pharmova LimitedJubilant FoodWorks LimitedEnterprise in which Key management personnel are interestedAny other transactionRental and other income20000000None806000000Jubilant Pharmova LimitedJubilant FoodWorks LimitedEnterprise in which Key management personnel are interestedSale of goods or services160000000None6452000000Jubilant Pharmova LimitedJubilant Generics LimitedStep down subsidiaryAny other transactionLease Payments100000000None4452000000Jubilant Pharmova LimitedJubilant Generics LimitedStep down subsidiaryAny other transactionRecovery of Expenses190000000None5905000000Jubilant Pharmova LimitedJubilant Generics LimitedStep down subsidiaryAny other transactionReimbursement of expenses230000000None3285000000Jubilant Pharmova LimitedJubilant Generics LimitedStep down subsidiaryAny other transactionRental and other income150000000None2440000000Jubilant Pharmova LimitedJubilant Generics LimitedStep down subsidiarySale of goods or services580000000None12912000000Jubilant Pharmova LimitedJubilant HollisterStier General PartnershipStep down subsidiaryAny other transactionRental and other income40000000None1516000000Jubilant Pharmova LimitedJubilant HollisterStier General PartnershipStep down subsidiarySale of goods or services40000000None338000000Jubilant Pharmova LimitedJubilant HollisterStier LLCStep down subsidiaryAny other transactionReimbursement of expenses10000000None188000000Jubilant Pharmova LimitedJubilant HollisterStier LLCStep down subsidiaryAny other transactionRental and other income100000000None4079000000Jubilant Pharmova LimitedJubilant HollisterStier LLCStep down subsidiarySale of goods or services300000000None15869000000Jubilant Pharmova LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionLease Payments30000000None1381000000Jubilant Pharmova LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionRecovery of Expenses805000000None335000000Jubilant Pharmova LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionReimbursement of expenses140000000None4862000000Jubilant Pharmova LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionRental and other income140000000None4911000000Jubilant Pharmova LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedPurchase of goods or services50000000None256000000Jubilant Pharmova LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedSale of goods or services390000000None17541000000Jubilant Pharmova LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedSale of fixed assets10000000None52000000Jubilant Pharmova LimitedJubilant Life Sciences (Shanghai) LtdEnterprise in which Key management personnel are interestedAny other transactionReimbursement of expenses40000000None1459000000Jubilant Pharmova LimitedJubilant Pharma Australia Pty LimitedStep down subsidiaryAny other transactionReimbursement of expenses10000000None70000000Jubilant Pharmova LimitedJubilant Pharma Holdings Inc.Step down subsidiaryAny other transactionReimbursement of expenses20000000None658000000Jubilant Pharmova LimitedJubilant Pharma Holdings Inc.Step down subsidiaryAny other transactionRental and other income10000000None12000000Jubilant Pharmova LimitedJubilant Pharma Holdings Inc.Step down subsidiarySale of goods or services2500000000None35474000000Jubilant Pharmova LimitedJubilant Pharma LimitedSubsidiaryDividend received0None33440000000Jubilant Pharmova LimitedMr. Arun SethKey management personnelAny other transactionCommission0None150000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. Arun SethKey management personnelAny other transactionSitting fees and director fees0None35000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. Arvind ChokhanyKey management personnelRemuneration0None1855000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. Hari S. BhartiaKey management personnelRemuneration0None87000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. Naresh KapoorKey management personnelRemuneration0None412000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. Rajiv ShahKey management personnelRemuneration0None65000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. S SridharKey management personnelAny other transactionCommission0None150000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. S SridharKey management personnelAny other transactionSitting fees and director fees0None48000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. Shirish G. BelapureKey management personnelAny other transactionCommission0None150000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. Shirish G. BelapureKey management personnelAny other transactionSitting fees and director fees0None35000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. Sushil Kumar RoongtaKey management personnelAny other transactionCommission0None150000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. Sushil Kumar RoongtaKey management personnelAny other transactionSitting fees and director fees0None53000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. Vivek MehraKey management personnelAny other transactionCommission0None150000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. Vivek MehraKey management personnelAny other transactionSitting fees and director fees0None55000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMs. Sudha PillaiKey management personnelAny other transactionCommission0None150000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMs. Sudha PillaiKey management personnelAny other transactionSitting fees and director fees0None58000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. R. KumarKey management personnelRemuneration0None952000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Consumer Private LimitedEnterprise in which Key management personnel are interestedAny other transactionRental and other income10000000None-5000000Jubilant Pharmova LimitedMr. Arjun Shanker BhartiaKey management personnelRemuneration0None3748000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedMr. Priyavrat BhartiaKey management personnelRemuneration0None3748000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Pharmova LimitedJubilant Agri and Consumer Products LimitedEnterprise in which Key management personnel are interestedAny other transactionRecovery of Expenses10000000None121000000Jubilant Pharmova LimitedJubilant Agri and Consumer Products LimitedEnterprise in which Key management personnel are interestedAny other transactionRental and other income40000000None429000000Jubilant Pharmova LimitedJubilant Agri and Consumer Products LimitedEnterprise in which Key management personnel are interestedSale of goods or services40000000None1664000000Jubilant Pharmova LimitedMr. Jinang Pratapbhai ParekhKey management personnelRemuneration0None378000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 11.5pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN'>Audit Committee approval is not required for payment of&nbsp;remuneration.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Jubilant Therapeutics Inc.Jubilant Epicore LLCSubsidiaryAny other transactionRecovery of Expenses50000000None1736000000Jubilant Therapeutics Inc.Jubilant Epicore LLCSubsidiaryInvestment330000000None5813000000Any otherIssuance of convertible promissory notes0.04415 YearsInvestment0Not applicableUnsecuredBusiness PurposeJubilant Therapeutics Inc.Jubilant Epipad LLCSubsidiaryAny other transactionRecovery of Expenses40000000None1333000000Jubilant Therapeutics Inc.Jubilant Epipad LLCSubsidiaryInvestment170000000None1871000000Any otherIssuance of convertible promissory notes0.04415 YearsInvestment0Not applicableUnsecuredBusiness PurposeJubilant Therapeutics Inc.Jubilant Episcribe LLCSubsidiaryAny other transactionRecovery of Expenses60000000None2089000000Jubilant Therapeutics Inc.Jubilant Episcribe LLCSubsidiaryInvestment330000000None1497000000Any otherIssuance of convertible promissory notes0.04415 YearsInvestment0Not applicableUnsecuredBusiness PurposeJubilant Therapeutics Inc.Jubilant Prodel LLCSubsidiaryAny other transactionRecovery of Expenses50000000None373000000Jubilant Therapeutics Inc.Jubilant Prodel LLCSubsidiaryInvestment170000000None1246000000Any otherIssuance of convertible promissory notes0.04415 YearsInvestment0Not applicableUnsecuredBusiness PurposeJubilant Therapeutics India LimitedJubilant Bhartia FoundationOther related partyAny other transactionDonation1000000None30000000Jubilant Therapeutics India LimitedJubilant Discovery Services LLCFellow subsidiaryAny other transactionRecovery of Expenses1030000None103000000Jubilant Therapeutics India LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionLease Payments10000None1000000Jubilant Therapeutics India LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionReimbursement of expenses490000None13000000Jubilant Therapeutics India LimitedJubilant Therapeutics Inc.SubsidiaryInterest received20000000None835000000Jubilant Therapeutics India LimitedJubilant Therapeutics Inc.SubsidiarySale of goods or services80000000None3546000000Jubilant Therapeutics India LimitedJubilant Therapeutics Inc.SubsidiaryInvestment50000000None4156000000Investment0.0455 YearsUnsecuredBusiness purposePSI Supply NVJubilant Life Sciences NVEnterprise in which Key management personnel are interestedAny other transactionReimbursement of expenses0None6000000PSI Supply NVJubilant Pharma UK LimitedFellow subsidiaryAny other transactionRecovery of Expenses0None452000000PSI Supply NVJubilant Pharma UK LimitedFellow subsidiarySale of goods or services0None3190000000TrialStat Solutions Inc.Jubilant DraxImage Inc.Fellow subsidiarySale of goods or services0None132000000TrialStat Solutions Inc.Jubilant Epicore LLCFellow subsidiarySale of goods or services20000000None92000000TrialStat Solutions Inc.Jubilant Life Sciences (USA) Inc.Enterprise in which Key management personnel are interestedAny other transactionRecovery of Expenses20000000None755000000TrialStat Solutions Inc.Jubilant Innovation (USA) Inc.Fellow subsidiaryAny other transactionBorrowings repaid0None2764000000Jubilant Business Services LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionLease Payments0None1000000Jubilant First Trust Healthcare LimitedJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionLease Payments20000None1000000Jubilant Employees Welfare TrustJubilant Ingrevia LimitedEnterprise in which Key management personnel are interestedAny other transactionLease Payments0None1000000